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ABSTRACT 
 
 Acute lymphocytic leukemia (ALL) is a life-threatening disease primarily 
affecting children.  Treatment currently consists of chemotherapy sometimes in 
combination with head irradiation.  The literature documents the damage of 
treatment to the teeth (e.g., congenital absence, microdontia, abnormal crown-
root ratios).  The present study assessed the effects of treatment for ALL on the 
tempos of dental maturation (i.e., dental age) in a mixed longitudinal sample of 
72 children treated for ALL at St Jude's Children's' Research Hospital, Memphis, 
Tennessee.  Panoramic radiographs had been taken as indicated to assess and 
maintain dental health in this retrospective study.  Dental age was quantified 
both on a tooth-specific basis and averaged across all scorable teeth using 
published standards for American whites.  The tempo of tooth formation was 
gauged as dental age (DA) minus chronological age (CA).  Children were 
developmentally normal (DA=CA) at the onset of ALL, and there was no sex 
difference in response to treatment.  No statistically significant developmental 
delay was found during the first two years from the onset of treatment, perhaps 
because tooth mineralization progresses slowly enough that effects were 
obscured. From two years onward, DA was significantly depressed.  The effect of 
chemotherapy alone only had a slight negative effect on DA.  The addition of 
irradiation to chemotherapy had a significant additive effect on DA, as well as 
 v
increasing the incidence of developmental variants such as stunted roots (i.e., 
roots with apical closure prior to achieving normal length).  Importantly, there 
was no evidence of a compensatory increase in the tempo of growth following 
treatment.  The chemotherapeutic treatment for ALL is a serious stressor to the 
body's tempo of growth, and the addition of irradiation therapy significantly 
adds to the negative effect on the tempo of dental maturation.  Significant 
developmental delay was not seen until two years after the start of treatment, 
either because the dentition is buffered from the stresses of treatment or because 
the morphological changes are slow to occur.  The end result of treatment for 
ALL is delayed tooth maturation in addition to the previously documented risks 
of developmental dental anomalies. 
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 CHAPTER I 
 
INTRODUCTION 
 
Leukemia is a malignant disease of the blood and its formative organs, in 
which there is an overproduction of leukocytes.  Leukemia results from the 
clonal proliferation of lymphoid precursors with arrested maturation (Cortes and 
Kantarjian 1995).  It can be classified as either lymphocytic or myelocytic 
leukemia depending on the type of cell that is altered, and can be further 
subdivided as detailed in Table 1.  Contemporary classification techniques use 
morphology, cytochemistry, differentiation antigens, cytogenetics, and molecular 
genetics to classify the type of leukemia. 
Acute lymphoblastic leukemia (ALL) comprises approximately 80 percent 
of all childhood leukemias.  The remaining 20 percent are divided among acute 
myeloblastic leukemia (AML), acute myelommonocytic leukemia (AMMoL), 
acute monocytic leukemia (AMoL), acute progranulocytic leukemia (APL), acute 
megakaryocytic leukemia (AMkL), and juvenile myelomonocytic leukemia 
(JMML) (Zipf et al. 2000). 
Leukemia is the most frequent form of childhood cancer.  It comprises 
about one third of the cancers in children under the age of 15.  Leukemia was the 
leading cause of death among children in the United States until the early 1980s.   
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Table 1.  Approximate relative frequency of  
leukemia in children. 
 
 
 
Leukemia type Percentage 
 
 
  
Lymphoid 
 
 
B-precursor 
 
 72 
 
 B-precursor - monocytic and/or 
myloid 
10  
 
T-cell 16  
B-cell 2  
   
Myeloid   
 Myeloid 50 
 Progranulocytic 7  Myelomonocytic 16  
Monocytoid 16  
Erythroid 2  
Megakaryocytic 6  
Juvenile myelomoocytic 3  
 
Source: Zipf TF, Berg SL, Roberts WM, Poplack DG, 
Steuber CP, Bleyer WA.  Childhood 
leukemias.  In:  Abeloff MD, Armitage JO, 
Lichter AS, Niederhuber JE, editors.  
Clinical oncology, 2nd ed.  New York:  
Churchill Livingstone, 2000, p 2402-34. 
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 Great progress has been made in improving event-free survival rates of the 
children affected by this tragic disease (Pui and Evans 1998).  Until every child 
can be free of leukemia, much more research is needed to increase our 
knowledge of this disease. 
The purpose of the present study was to assess the affects of ALL 
treatment on the tempos of dental maturation evaluated as dental age.  This 
project primarily addressed this question:  To what degree is the tempo of tooth 
mineralization suppressed in children following treatment for ALL?  
3
 CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
Epidemiology 
Although the overall incidence of ALL has remained constant over the 
past three decades, new information concerning subgroups continues to be 
uncovered (Smith et al. 1997).  On the order of 2,500 to 3,500 children are 
diagnosed with ALL each year in the United States, with an incidence of 3 to 4 
cases per 100,000 white children (Gurney et al. 1995; Greenlee et al. 2000).  The 
peak incidence of ALL occurs between age 2 and 5 years, and it may be trending 
downward in the United States (Swensen et al. 1997).  ALL is more common 
among white children than black children in the United States.  It also is more 
common in boys than in girls, and this sex difference is greatest among pubertal 
children (Swensen et al. 1997; Haddy 1982). 
 
Etiology 
The molecular basis for leukemic transformation from a normal 
hematopoietic cell to a malignant cell in humans is unknown, but it is known to 
be a genetic alteration of a hematopoietic cell (Zipf et al. 2000).  In normal bone 
marrow, undifferentiated pluripotent progenitor cells have the ability for self-
4
 renewal, and they give rise to committed progenitor cells.  These are 
morphologically recognizable cells that differentiate into erythroid, myeloid, 
megakaryocytic, eosinophilic, and monocytic-macrophage cell types.  In the 
clonal expansion theory (Mahoney 1999), leukemia arises from a damaged 
progenitor cell that has the tendency for unlimited self-renewal or has lost the 
ability to differentiate along the lines of normally differentiated progenitor cells.  
The modal age of onset seems to coincide with children’s growth and 
proliferation of their lymphoid tissue and first exposures to infection (Zipf et al. 
2000). 
Although the cause of ALL is unknown, there are a number of genetic, 
environmental, viral and immunologic factors that may contribute to the 
development of the disease. 
 
Genetic Factors 
An unusual susceptibility to leukemia has been associated with certain 
heritable diseases, chromosomal disorders, and constitutional syndromes (Figure 
1) (Mahoney 1999).  Children with Down’s syndrome (trisomy 21), Bloom’s 
syndrome, Fanconi’s anemia, Klinefelter’s syndrome (gonadal dysgenesis) and 
ataxia telangiectasia are all at higher risk than the general population for 
developing leukemia (Zipf et al. 2000). 
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Down’s syndrome (trisomy 21) 
Bloom’s syndrome 
Ataxia-telangiectasia 
Wiskott-Aldrich syndrome 
Fanconi’s anemia 
Diamond-Blackfan syndrome 
Scwachman’s syndrome 
Klinefelter’s syndrome (gonadaldysgenesis) 
Turner’s syndrome (45, XO) 
Multiple neurofibromatosis 
Severe combined immunodeficiency syndrome 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.  Constitutional disorders with high risk 
of leukemia. 
 
Source: Zipf TF, Berg SL, Roberts WM, Poplack DG, 
Steuber CP, Bleyer WA.  Childhood 
leukemias.  In:  Abeloff MD, Armitage JO, 
Lichter AS, Niederhuber JE, editors.  
Clinical oncology, 2nd ed.  New York:  
Churchill Livingstone, 2000, p 2402-34. 
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 Reports have identified families with multiple members affected by 
leukemia (Gunz et al. 1978).  Children with an affected sibling and, especially, 
twins are at greater risk of developing leukemia, although this risk may be only 
approximately twice that of the general population and applies to twins whose 
affected sibling was diagnosed before age 5 to 7 years of age (Zipf et al. 2000). 
Some cases of ALL may be related to hereditary or acquired mutations in the p53 
gene.  ALL is the usual outcome in infants and preschool children with the 
myelodysplastic syndrome associated with hematopoietic cell monosomy 7 or 
deletion of the long arm of chromosome 5 (Zipf et al. 2000). 
 
Environmental Factors 
Exposure to radiation is a risk factor for ALL (Cortes and Kantarjian 1995).  
Ionizing radiation has been the most extensively studied of the various 
environmental factors leading to ALL (Mahoney 1999).  Exposure in utero 
increases the risk of ALL, and exposure to therapeutic radiotherapy may also be 
leukemogenic (Cortes and Kantarjian 1995). 
Stewart, Webb and Hewitt (1958) documented increased mortality due to 
leukemia among children of mothers who had received diagnostic radiographs 
during pregnancy. 
The carcinogenic effects of low-level radiation were studied by Lyon et al. 
(1979).  The study examined the population of Utah because of its exposure to 
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 fallout from 26 nuclear tests between 1951 to 1958, and the study reviewed all of 
the deaths from childhood cancer.  The counties in Utah were categorized into 
either a low or high exposure group and matched with a county of the opposite 
group for control purposes.  The high exposure areas showed a higher risk of 
developing leukemia than did the low exposure areas.  The authors suggested 
that the increase in leukemia deaths could have been due to fallout or some other 
unidentified factor. 
The relative risk of developing leukemia or other forms of cancer in 
persons exposed to electromagnetic fields has been investigated in several 
studies, but no definitive cause and effect has been established (Mahoney 1999). 
 
Viral Factors 
A viral etiology of leukemia has been explored for several years.  
Although viral agents have been accepted as a cause of leukemia in mice, the 
evidence in human leukemia for a viral agent is still incomplete (Anderson and 
Scotti, 1980).  A small number of RNA viruses have known oncogenic potential.  
RNA viruses, such as the Rous sarcoma virus and the feline leukemia virus, have 
caused oncogenic transformation in a variety of animal species, but they have not 
been associated with cross-species transmission or with cancer in humans 
(Mahoney 1999). 
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 The human T-cell lymphotrophic virus (HTLV-I) is a retrovirus that has 
been isolated from a subset of patients with adult T-cell leukemia.  Whether the 
HTLV-I agent is a cause of leukemia remains to be established (Mahoney 1999). 
 
Immunologic Factors 
Several immunodeficiency states have an associated increased risk for 
leukemia.  These conditions include the syndromes of Wiskott-Aldrich, 
congenital hypogammaglobulinemia, X-linked agammaglobulinemia, and severe 
combined immune deficiency (Mahoney 1999; Margolin et al. 2002). 
 
Types of Acute Lymphocytic Leukemia 
 
Morphological Classification 
There have been multiple efforts to classify ALL cells morphologically 
using criteria such as cell size, nuclear to cytoplasmic ratio, nuclear shape, 
number and prominence of nucleoli, nature and intensity of cytoplasmic staining 
with a variety of staining agents, presence of cytoplasmic granules, prominence 
of cytoplasmic vacuoles, and the character of nuclear chromatin.  Most of these 
efforts have been unsuccessful because they were technically difficult to 
reproduce or they lacked meaningful clinical correlations (Margolin et al. 2002). 
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 In 1976, a French-American-British (FAB) cooperative group developed a 
system for morphological classification of acute leukemias.  The acute 
lymphoblastic leukemias were divided into three classes:  L1, L2 and L3.  L1 
lymphoblasts are small, with scant cytoplasm and indistinct nucleoli.  Cells of the 
L2 type are larger, more heterogeneous in size, and have more abundant 
cytoplasm, prominent nucleoli, and reniform nuclear membranes.  Lymphoblasts 
of the L3 type are large, with a deep cytoplasmic basophilia, prominent 
vacuolation, one or more nucleoli and are morphologically identical to Burkitt’s 
lymphoma cells (Bennett et al. 1976, 1981).  Approximately 85% of the children 
with ALL have lymphoblasts of L1 morphology.  Fewer than 15% of patients 
have lymphoblasts of L2 morphology, and 1% has L3 (Foon and Todd 1986).  L1 
morphology has been associated with a higher remission induction rate and 
better event-free survival (EFS) than L2 morphology, which appears to convey 
poor prognosis (Miller et al. 1981). 
 
Immunophenotyping 
Immunophenotyping plays an important role in the diagnosis of the acute 
leukemias.  It is a more clinically relevant classification of ALL and is based on 
expression of certain antigens on the surface of leukemic cells (Cortes and 
Kantarjian 1995).  The clinician is able to determine whether the leukemia is 
lymphoid or myeloid in origin through the use of monoclonal antibodies specific 
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 for various stages of B-cell, T-cell, and myeloid differentiation (Rubnitz and Look 
2000).  In most cases, immunophenotyping also permits assignment of the 
relative stage in the process of B- or T-cell differentiation from which the 
leukemic clone is believed to have arisen.  Approximately 80% to 85% of cases of 
childhood ALL are supposed to develop from the monoclonal proliferation of B-
cell precursors (Zipf et al. 2000). 
Newly diagnosed patients with ALL occasionally show an abnormal 
immune system (Konioe and Leventhal 1976).  Abnormally low serum 
immunoglobulin levels have been observed in as many as 30% of patients.  It is 
unclear whether these abnormalities precede the development of leukemia or are 
a consequence of the disease (Margolin et al. 2002). 
 
Clinical Manifestations 
Patients with ALL present most frequently with signs and symptoms of 
the uncontrolled growth of leukemic cells in bone marrow, lymphoid structures, 
and other sites of extramedullary spread (Berg 2000).  The most common 
presenting symptoms are fever, pallor, purpura, and pain (Mahoney 1999).  The 
symptoms and the frequency of occurrence in patients of ALL are listed in Table 
2 (Mahoney 1999).  Bone marrow involvement results in varying degrees of 
anemia, thrombocytopenia, and granulocytopenia that may be manifested by 
pallor and fatigue, petechiae, purpura or bleeding, and fever (Berg 2000).  Liver,  
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Table 2.  Frequency of symptoms associated with 
acute lymphocytic leukemia. 
 
 
 
Symptoms Frequency (%) 
Fever 43-61 
Pallor 39-55 
Bleeding 24-55 
Bone/joint pain 31-38 
Abdominal pain 9-19 
Anorexia 17-33 
Fatigue 30 
 
 
 
 
 
 
 
 
 
 
Source: Mahoney DH III.  Acute lymphoblastic 
leukemia.  In:  McMillan JA, editors.  Oski’s 
pediatric principles and practice, 3rd ed.  
Philadelphia:  Lippincott Williams & Wilkins, 
1999, p 1491-1501. 
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 spleen, and nodal enlargement is present in most patients and are the most 
common sites of extramedullary spread of the disease (Berg 2000).  Symptoms 
may be present from a few days to several weeks before the diagnosis of ALL is 
made, although in some cases a relevant clinical history may precede diagnosis 
by several months (Berg 2000).  At first, symptoms may be nonspecific and may 
mimic other nonmalignant conditions, and this nonspecific nature of the signs 
and symptoms of ALL occasionally leads to delay in diagnosis (Mahoney 1999; 
Berg 2000). 
 
Laboratory Manifestations 
A wide variety of abnormalities can be observed in the clinical laboratory 
data obtained when the patient presents for diagnosis (Zipf et al. 2000).  Over 
90% of patients with ALL have clinically evident hematologic abnormalities at 
diagnosis (Berg 2000).  The white blood cell count is highly variable among 
patients and may be more than 1,000,000/μl; whereas the range of normal is 
4,500 to 100,000/μl.  In approximately 50% of patients, the initial white blood cell 
count is elevated; in up to 25% it is greater than 50,000/μl at initial presentation.  
Despite the elevation in leukocyte count at diagnosis, however, many patients 
present with severe neutropenia (defined as < 500 granulocytes/mm3) and are at 
significant risk of serious infection (Bodey et al. 1966).  Thrombocytopenia is 
extremely common; over three fourths of patients present with platelet counts 
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 less than 100,000/μl; whereas the range of normal for platelets is 150,000 to 
400,000/μl.  (Zipf et al. 2000).  Only approximately one third of patients have a 
platelet count less than 50,000/μl at diagnosis (Zipf et al. 2000).  The majority of 
patients with ALL will have platelet counts below 100,000/μl, and a count below 
10,000/ μl is not uncommon, yet the platelet size is usually normal (Zipf et al. 
2000).  Although petechiae and purpura are present in many patients, severe 
bleeding is unusual at initial presentation, even when the platelet count is less 
than 20,000/μl, unless fever, infection, or an accompanying coagulopathy, such 
as disseminated intravascular coagulation (DIC), are also present (Zipf et al. 
2000). 
 
Oral Manifestations 
Curtis (1971a) reviewed the records of 464 patients with a diagnosis of 
leukemia who had been admitted to St. Jude Children’s Research Hospital, 
Memphis, Tennessee.  Only patients who had been diagnosed within one week 
before admission and who had received no prior antineoplastic treatment were 
evaluated for initial oral manifestations of leukemia.  Of this sample, 98% were 
diagnosed with ALL.  Curtis found that in patients with ALL, petechiae and 
ecchymosis were the most frequent intraoral findings, followed by pallor, ulcers 
and bleeding.  He reported that gingival hypertrophy was only seen in 3% of 
children in this study prior to treatment.  He found that only a small percentage 
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 of the patients with ALL had pronounced oral manifestations.  Curtis stated that, 
“The early age at diagnosis within this group, when relatively little degeneration 
has taken place, may be a contributing factor” (Curtis 1971a:163). 
Michaud et al. (1977) examined 77 patients with acute leukemia for oral 
manifestations of the disease.  These children were examined in various stages of 
the disease and the examiners found lymph node enlargement in the submental, 
submandibular, anterior and posterior cervical and the preauricular and 
postauricular lymph nodes in 30 of the 77 patients.  They noticed oral ulcerations 
in 28 patients and erosions of the oral mucosa in 23 patients.  These erosions 
were present primarily on the buccal mucosa and hard palate.  Punctate 
petechiae were among the most common findings and were encountered in 46 
patients, mainly on the lips and buccal mucosa.  Ecchymoses were also found, 
either isolated or interspersed between petechiae.  Ecchymoses were not 
observed in patients whose platelet counts were greater than 50,000/mm3.  
Candidiasis of the oral mucosa was observed in 21 patients.  Only three patients 
with ALL showed evidence of gingival hypertrophy, and three others had 
unilateral defects of the soft palate above the tonsillar pillars.  These defects 
resembled a shallow traction diverticulum and varied from 2 to 5 mm in 
diameter. 
Sonis, Sonis and Lieberman (1978) studied patients being treated for 
malignancies other than of the head and neck to determine associations between 
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 oral problems and the type of malignancy and therapy.  The purpose of their 
study was to evaluate the distribution and type of oral problems in these 
patients.  Of the 15 patients with leukemia, abnormal oral conditions developed 
in 10.  The most frequent oral complications were ulceration, mucosistis and 
xerostomia, and these were seen most often in patients with leukemia at 67% and 
Hodgkin’s disease at 100%.  Patients with leukemia also exhibited moniliasis, 
cellulites, abscesses, and acute necrotizing ulcerative gingivitis (ANUG).  They 
also reported that younger patients (ages 1 to 20) had a higher prevalence of oral 
complications than older patients (ages 21 to 40; 41 to 60; 61 or older). 
Curtis (1971b) examined 374 panoramic dental radiographs of 214 
children admitted to St. Jude Children’s Hospital for the diagnosis or treatment 
of acute leukemia.  The panoramic radiographs were studied for loss or thinning 
of the bony crypts of developing teeth and for loss of the lamina dura of the 
erupted teeth, and for the displacement of teeth.  On dental radiographs, the 
earliest sign of acute leukemia (i.e., manifestations of the disease within the bone) 
was noted as destruction of the mandibular alveolar bone in the apical portion of 
the most distal developing molar crypt and the apical portions of the premolar 
and canine crypts.  Alterations of the jaws were reported for 63% of the children 
with active leukemia.  He stated that destruction of the apical portion of the most 
distal developing molar crypt was the abnormality most frequently encountered 
in the mandible.  The apical portions of the premolar and canine crypts were the 
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 regions next most frequently involved.  Curtis commented that active 
hematopoiesis continues in the jaws until puberty and thereafter usually 
decreases with age.  Since leukemia is a disease of the hematopoietic tissues and 
affects the bone marrow in general, the alterations seen in the jaws of children 
are not unexpected. 
Kaste et. al. (1997) examined panoramic radiographs for dental 
abnormalities in 423 children treated for ALL at St. Jude Children’s Hospital.  All 
patients were treated with multiagent chemotherapy and 243 of the 423 children 
received cranial irradiation in addition to the chemotherapy.  Dental 
abnormalities includes root stunting, microdontia, hypodontia, taurodontia , and 
over-retention of primary teeth.  The children that received the cranial irradiation 
developed more dental abnormalities than those who only received 
chemotherapy. 
 
Basic Chemotherapeutic Principles 
 After the identification of effective neoplastic drugs in the 1940s and 1950s 
the development of combination chemotherapy occurred in the 1960s at research 
hospitals across the country, including St. Jude Children’s Research Hospital, 
Memphis, Tennessee.  Since that time, refinements in combination chemotherapy 
have led to what is now referred to as risk-adapted therapy, which has increased 
remission rates to today’s levels of around 80 percent (Pui 1997).  The objective of 
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 this therapy is to eliminate the neoplastic cells with as little detriment as possible 
to the normal cells of the body.  The protocol for risk- adapted therapy includes 
four major elements:  remission induction, intensification-consolidation, 
prevention of overt CNS disease, and continuation of remission (Pui 1997). 
 
Current Therapy for ALL 
The beginning phase in treatment of ALL is induction therapy.  The goal 
here is to induce complete remission with restoration of normal hematopoiesis 
(Pui and Evans 1998).  The induction regimen includes doses of glucocorticoid 
(prednisone or dexamethasone), vincristine, and L-asparaginase (Pui and Evans 
1998).  This combination of chemotherapeutic agents should induce complete 
remission in 98% to 99% of children with newly diagnosed ALL (Pui 1997). 
The next stage is intensification or consolidation therapy.  This is designed 
to eradicate residual blast cells (Pui 1997).  It consists of several drugs 
administered shortly after the induction of remission (Pui and Evans 1998).  The 
drug regimen often includes high doses of methotrexate with or without 6-
mercaptopurine, high doses of asparaginase for an extended period and 
epipodophyllotoxin plus cytarabine.  Alternatively, a combination of vincristine, 
dexamethasone, asparaginase, doxorubicin, and thioguanine may be given with 
or without cyclophosphamide (Pui and Evans 1998).  This stage of therapy has 
been shown to improve outcomes, even in patients with low-risk ALL (Chessells 
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 et al. 1995).  Research has suggested that intensive multidrug therapy begun after 
induction of remission results in longer lasting remissions (Cortes and Kantarjian 
1995). 
The control of subclinical CNS leukemia is the next step in treatment.  
Most children with leukemia have subclinical CNS involvement at the time of 
diagnosis (Pui 1995).  This CNS leukemia can be eliminated by extended use of 
age-adjusted doses of intrathecal chemotherapy (Tubergen et al. 1993; Pullen et al. 
1993).  Studies have shown that additional doses of intrathecal chemotherapy 
and more intensive systemic treatment may replace cranial irradiation for 
prevention of CNS leukemia relapse (Conter et al. 1995). 
 
Tooth Formation 
Many descriptions of the process of tooth formation as seen at the level of 
light microscopy have been written over the past several decades.  Since the 
histological details have generally been worked out, these descriptions are 
concordant, and the fundamentals of tooth formation and maturation are 
considered common scientific knowledge today.  The following description of 
tooth formation is a compilation of these works:  Arey (1965), Slavkin (1974), 
Corliss (1976), Provenza (1986), Moss-Salentijn (1990), Bhaskar (1991), Melfi 
(1994), Ten Cate (1994), Sperber (2001), and Ash (2003).  Except where noted, the 
description is invariant among these authors. 
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 Teeth develop from two of the primary germ layers, mesoderm and 
ectoderm, along with a neural crest contribution.  The enamel of teeth is derived 
from oral ectoderm.  The mesoderm forms the cementum and the periodontal 
membrane.  Ectomesenchyme provides material for the dentine and pulp.  The 
term ectomesenchyme is used to indicate that these mesenchymal cells originate 
from ectoderm (from the neural plate) and not from mesoderm, and these cells 
migrate from the neural plate ecotderm into their final position in the head.  
Ectomesenchymal-epithelial inductive interactions between neural crest tissue, 
pharyngeal endoderm and oral ectoderm induce ectodermal epithelial 
proliferation that produces the first morphologically identifiable manifestation of 
teeth, the odontogenic epithelial islands.  The neural crest cells, in turn, are later 
induced to form the individual dental papillae, indicating the future number of 
teeth. 
The first indication of tooth development is an epithelial plate (also called 
the dental lamina) about the 37th day of development (Fig. 2).  In the maxilla this 
dental lamina is formed from the coalescence of four maxillary odontogenic 
epithelial islands and in the mandible there is a fusion of two odontogenic 
epithelial zones at the midline.  The upper and lower dental laminae become a 
thickened horseshoe-shaped plate (band) that lies on the presumptive maxillary  
20
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2 1
 and mandibular alveolar ridges.  This band of tissue invades the underlying 
mesenchyme and proliferates at an accelerated rate in ten places in both the 
maxillary and mandibular arches.  These centers of increased mitosis will 
become the enamel organs (dental organs) for the developing primary teeth.  The 
presumptive dental organs penetrate deeper into the underlying mesenchyme as 
they develop.  The dental organs, which are knob-like thickenings along the 
dental lamina, also become submerged deeper into the mesenchyme because of 
occlusal growth of the maxillary and mandibular ridges. 
Another, and later, subjacent proliferation of the oral epithelium occurs 
buccally and labially to the dental laminae and is known as the vestibular 
lamina.  Degeneration (apoptosis) of the central epithelial cells of the vestibular 
laminae in the upper and lower jaws results in the formation of a sulcus, the 
vestibule, that will separate the lips and cheeks from the tooth-bearing gingival 
mucosa. 
Early in the third month in-utero, the deeper side of each dental organ 
presses against a dense accumulation of mesenchyme and alters its initially small 
bud shape by enlarging and flattening out as a result of disproportionately rapid 
mitosis of the basal cells into a cap shape, and later cupping into a large bell 
shape (Fig. 3).  The lumen of the cap (or cup) is filled with dense mesenchyme 
that will become the dental papilla.  The dental organ will  
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 determine the shape of the crown, initiating dentin formation, establishing the 
dentogingival junction, and forming enamel, while the dental papilla will form 
the dentine and the pulp.  The dental follicle is formed when the connective 
tissue beneath the dental papilla becomes fibrous and encircles the papilla and 
part of the enamel organ.  The enamel organ, dental papilla and dental follicle 
together constitute the tooth germ.  The tooth germ is still connected to the oral 
epithelium by means of the dental lamina that is attached to the dental organ.  
This tooth germ continues to enlarge and the cap becomes more bell shaped. 
Concomitant with these morphological alterations, histodifferentiation 
occurs within the enamel organ and four distinct layers are discernible in its 
epithelium:  the outer enamel epithelium (low cuboidal cells), the stellate 
reticulum (star shaped epithelial cells), the stratum intermedium (flat epithelial 
cells), and the inner enamel epithelium (cuboidal cells).  The inner enamel 
epithelium is separated from the dental papilla by a basement membrane (i.e., 
acellular zone), which will ultimately become the dentoenamel junction. 
The cells on either side of the basement membrane continue to develop in 
preparation for production of tooth structure.  At the sites of the future cusp tips, 
where dentin will first be formed, mitotic activity ceases, and the small cuboidal 
cells of the inner enamel epithelium elongate and differentiate into ameloblasts 
(columnar cells) and prepare to lay down enamel.  As these morphological 
changes occur in the cells of the internal enamel epithelium, changes also occur 
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 within the adjacent dental papilla.  The cells of the dental papilla approximate 
the basement membrane and differentiate into columnar shaped odontoblasts 
(dentine forming cells).  The formation of dentine by the odontoblast precedes 
and is necessary for the further induction of ameloblasts to produce enamel 
(reciprocal induction). 
On the inner surface of the basement membrane, the odontoblasts begin 
the process of dentinogenesis at the incisal or cuspal area and progresses in an 
apical direction.  The cells lay down a fibrillar matrix that mineralizes, but also 
leave an extension of the cell (odontoblastic process) imbedded in the material.  
The odontoblastic processes are vital cellular material and do not mineralize, but 
behave as if points of the cell membrane were stuck to the basement membrane.  
These processes elongate as the odontoblast move away from the basement 
membrane, toward the center of the pulp and lay down matrix.  The end result is 
that the part of the cell with the nucleus comes to be some distance from the 
basement membrane, but it still is in physical contact with it through the 
odontoblastic processes. 
The process of matrix formation of dentinogenesis begins at the time the 
odontoblasts differentiate form the mesenchyme of the pulp.  Korff’s fibers 
(heavy corkscrew shaped collagen type I fibers) are laid down at the time of 
differentiation and as the odontoblasts migrate away from the basement 
membrane, the fibers unravel and spread out among the odontoblastic processes.  
25
 These processes and the ground substance are produced by the odontoblasts and 
this material is called predentine or dentinoid before it is mineralized.  The 
predentine is mineralized progressively and the part proximal to the pulp is last 
to form and mineralize.  Once dentine has been produced by the dental papilla it 
is then that the remnants of the dental papilla are termed the dental pulp. 
Ameloblasts are unable to produce enamel matrix until some dentine has 
been lain down.  They produce an organic matrix that facilitates the 
crystallization of mineral salts out of solution and creates enamel.  Enamel 
formation begins at the incisal or cuspal surfaces and follows the same pattern as 
dentine formation.  The ameloblasts move away from the basement membrane 
(now the dentoenamel junction) and leave enamel matrix behind.  The cells lay 
down the matrix in such a way that it looks like a string of beads in close 
proximity to one another and flattened.  This arrangement allows for the 
formation of the enamel rods and interrod substance that is apparent in mature 
enamel.  It is thought that the beads compartmentalize the matrix and that the 
substance of each rod is contributed to by more than one ameloblast. 
Once enamel matrix production has been completed, mineralization is 
complete and the enamel organ is reduced to a layer of ameloblasts and a few 
other epithelial cells.  The ameloblasts eventually flatten as well and appear as 
normal epithelial cells covering the newly formed crown (called the reduced 
enamel epithelium).  At this point, the reduced enamel epithelium produces the 
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 enamel cuticle (secondary enamel cuticle).  The reduced enamel epithelium 
becomes the junctional epithelium upon emergence of the crown into the oral 
cavity. 
Though enamel formation stops at the termination of the enamel organ, 
dentine formation continues apically to form the root of the tooth.  The crown of 
the tooth begins to move occlusally during root formation, but the tooth will not 
emerge into the oral cavity until a considerable portion of the root has formed.  
Dentine production and root elongation continues from one to four years after 
emergence to complete the root.  Production of dentine will enclose the pulp 
canal and eventually form the apical constriction (foramen) that signifies 
completion of the root, so-called root apexification. 
Tooth development and bony growth and development of the jaws are 
interdependent and the timing is critical for proper positioning and eventual 
eruption of the teeth.  The anterior primary tooth germs (central incisor, lateral 
incisor, canine and first molar) develop first, beginning in the sixth week 
postconception, while the second primary molar germs first appear at the 
seventh week.  Also at this time, the dental lamina is beginning to break down 
except for the free edge (this secondary dental lamina develops lingual to the 
primary tooth germ) that persists to form the primordia of the succedaneous 
teeth.  The tooth germs of the secondary teeth that do not replace primary teeth 
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 also form at this time from the primary dental lamina, but they are not associated 
with a developing primary tooth. 
 
Crown Development 
With the growth of the inner enamel epithelium (IEE), various regions of 
the formative crown respond allometrically to create the topography of cusps, 
ridges, pits and grooves (Korenhof 1960; Kraus and Jordan 1965; Ooë 1981).  
Attention now focuses on the primary and secondary enamel knots that direct 
the folding of the IEE that results in characteristic crown morphologies. 
 It has been long recognized as histological features that enamel knots 
begin to form in the cap stage of tooth development (reviewed in Butler 1956).  
Location of the primary enamel knot probably coincides with the presumptive 
apex of the first-forming cusp (Jernvall et al. 1994; Thesleff et al. 2001), which is 
the paracone (mesiolingual cusp) on the human upper molars.  Subsequently, 
during the bell stage the ostensible secondary enamel knots develop and coincide 
with the number and positions of the other presumptive cusps. 
 Enamel knots are transitory condensations of the IEE that project toward 
the dental papilla (Butler 1956).  They consist of non-dividing cells, which is 
significant since these knots seen to be control centers that stimulate rapid 
proliferation of adjacent dental epithelium though they themselves are 
nonproliferative (Jernvall et al. 1994; Luuko et al. 2003).  This seems to be an 
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 essential relationship to the formation of tooth cusps (Jernvall et al. 2000).  
Enamel knots define the number and modulate the spatial relationships of the 
presumptive cusp tips.  Topographic differences in proliferation rates of the 
epithelium account for the angularity of the cusps—at least as expressed at the 
enamel-dentin interface (Butler 1967a,b, 1968) as well as the differences in cusp 
heights.  The paracone begins mineralizing first on maxillary molars 
(Christensen and Kraus 1965; Kraus and Jordan 1965) so its apex is highest.  The 
later-forming hypocone’s apex is lower since occlusobasal development has 
progressed before its differentiation.  This leaves the talon lower than the trigon 
(Gregory 1922; Ziesz and Nuckolls 1949; Swindler 2002). 
 The location of the enamel knots do not account for all of the variation in 
intercusp relationships because (1) there is significant allometric growth of the 
IEE before dentinogenesis “freezes” the size and shape of the DEJ (Turner 1963; 
Ooë and Nomata 1964; Butler 1967a,b) and (2) the accretion of enamel alters 
intercusp relationships because depositioin is not uniform (Kraus 1952; Hillson 
and Bond 1997; Smith et al. 1997; Peretz et al. 1988a,b). 
 A series of prenatal specimens at ages prior to mineralization of the 
intercuspal regions (dentinogenesis precedes amelogenesis, so it actually is 
dentine deposition that terminates intercuspal dimensions at the DEJ) was used 
by Butler (1967b) to quantify the intercusp distance of the human maxillary first 
molar.  Butler shows that the paracone-metacone distance for UM1 is around 1 
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 mm when these cusp tips are first recognizable and this distance increases to 
about 4 mm before mineralization fixes the definitive distance.  The pattern of 
growth, at least for this one distance, appears to be linear (Butler 1967b).  
Intercuspal growth increases overall crown area, and the time- and rate-specific 
differences in growth rates produce species-specific crown morphologies as well 
as the inter-individual variation within a group (Peretz et al. 1997, 1998a,b; 
Salazar-Ciudad et al. 2002). 
Generally, the cusp tip, which is specified as the enamel of a mature tooth, 
is typically to the side, buccal or lingually, of the apex defined at the DEJ.  As the 
enamel thickens the cusp tip is shifted buccally on the paracone and metacone 
and lingually (palatally) on the protocone and hypocone in relation to the 
underlying prominences at the DEJ illustrating the moving of the cusps tips in 
opposite directions as amelogenesis proceeds (Kraus 1952).  
 
Root Formation 
Following the completion of crown morphogenesis and the elaboration of 
coronal dentin and enamel extracellular matrix, the developing tooth germ 
begins to form its root, a process that will establish its connection to the 
surrounding bone.  The mesenchyme that surrounds the enamel organ (dental 
sac) and that situated within the developing pulp is contiguous and derived from 
cranial neural crest ectomesenchyme.  This mesenchyme and particularly that 
30
 portion situated in the apical portion of the tooth germ, proliferates throughout 
the period of root development, generating not only cell populations that will 
contribute to the developing radicular pulp but also those that will form the 
developing periodontium.  The epithelial root sheath, derived from cells of the 
cervical loop of the enamel organ, proliferates apically, thereby establishing the 
demarcation between pulp and periodontium (Thomas 1995). 
Epithelial root sheath cells initiate the differentiation of odontoblasts that 
form root dentin (Ten Cate 1994).  Distinct differences between crown and root 
dentine formation have been described (Ten Cate 1978; Beertsen and Niehof 
1986), particularly during predentin secretion.  Morphological differences are 
apparent between fully differentiated odontoblasts in the crown and root; 
coronal odontoblasts are columnar, root odontoblasts are cuboidal (Avery 1986).  
Differences have been described in the biochemical composition of root dentin 
when compared with crown dentine (Steinfort et al. 1989).  Also the phosphoryn 
content of root dentine is less than that of coronal dentin, its degree of 
mineralization is slightly less, and the rate of deposition of root dentin is slower 
Ten Cate 1994). 
The odontoblast moves centripetally, leaving behind the formed dentin.  
How such movement takes place has not been studied.  The cell, as it migrates, 
leaves behind a process that comes to occupy a tubule within the mineralized 
dentin.  Thus the dentinal tubule is a permanent record of the track of the 
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 odontoblasts, which in coronal dentin is S shaped and in root dentin straight 
(Ten Cate 1994). 
 
Physiological Age 
 Physiological age (also called “biological age” or “developmental age”) is 
the age of the subject as judged by normal functional developmental processes, 
that is, the degree of maturity of the biologic tissue and organ systems an 
individual has achieved (Moorrees et al. 1963).  Most children are “average 
maturers” by definition; their physiological and chronological ages coincide 
fairly closely.  Other children developmentally lag behind their calendar ages, 
and these are called “late maturers” and “delayed growers.”  Others develop 
faster than indicated by their chronological age; these are called “early 
maturers.”  Tempo of growth is the rapidity with which an individual achieves 
biological maturity.  When the tempo of growth is faster or slower than average, 
the use of the child’s chronological age can be misleading relative to his growth 
potential. 
The link between growth and maturity has been described by Tanner et al. 
(1975) who stated that, “The normal growth process takes every individual from 
one common condition of being wholly immature to another of being wholly 
mature.”  Roche (1986) defined attaining maturity as the sequential alterations of 
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 a body, an organ or a tissue as it changes from an embryonic stage until it attains 
its adult form and functional level. 
 
Maturity in Relation to Age 
Tanner et al. (1975) stated that, in general, the use of an age scale for 
maturity measurements, and vice versa, is not advisable because of the following 
weaknesses.  First, it fails at the extremes.   For example, in skeletal maturity no 
particular age can be associated with an individual whose bones are all fully 
mature, although his status of 100% skeletal maturity is unequivocal.  Second, 
and more important, the relationship between actual age and maturity is not 
necessarily constant from one population to another or from one time to another, 
so unless the maturity scale is continuously redefined and updated in relation to 
the actual age, the result will be that the maturity scale and age do not 
correspond to each other.  Tanner et al. concluded that it is more proper to view 
maturity in a manner that does not refer directly to age, but rather study 
maturity and its relation to age as a second step in any given population, and 
produce “maturity standards” that can be updated. 
Van Wieringen (1986) stated that maturity, in relation to age, varies from 
one ethnic group to another, from one individual in the same ethnic group to 
another, and from one generation to another in the same population, which is a 
phenomenon known as a secular trend. 
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 Maturational events associated with puberty can be very useful, but, of 
course, they are not applicable before or after the narrow range of a few years in 
early adolescence (Tanner 1962).  Methods that are uniformly applicable 
throughout the span from birth to biological adulthood are more useful.  Bone 
age and dental age are such methods.  To be most useful, a method should meet 
four criteria:  (1) the same technique should be uniformly applicable throughout 
growth; (2) the technique should be uniformly applicable on males and females; 
(3) the method should be available for routine clinical use, not be complex, 
expensive or difficult to perform as required; and (4) the technique should be 
based on an invariant sequence of developmental events. 
 
Assessment of Dental Age 
There are various methods of determining dental age.  One common 
method uses eruption of teeth into the oral cavity (e.g., Filipsson 1975; Liversidge 
et al. 2003).  Another method for determining dental age involves a determination 
of the degree of mineralization of the teeth using radiographs (Moorrees et al. 
1963; Anderson et al. 1976) or histological sections (Kronfeld 1935a,b; Kraus and 
Jordan 1965).  The histological method will reveal more details than the 
radiographic method, but it is invasive.  Gleiser and Hunt (1955) suggested that, 
on an individual basis, tooth mineralization is superior to emergence for 
assessing dental age because of the greater spectrum of events involved in tooth 
formation.  Clinical emergence is a fleeting event; in contrast mineralization can 
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 be evaluated at any time during the span of active growth of the tooth.  The ease 
and frequency at which radiographs can be taken make this method the best 
approach to monitoring a child’s dental development (Harris 2002).  Fanning 
(1961, 1962) suggested that mineralization is superior to tooth emergence for 
assessing dental age because emergence can be influenced by local 
environmental factors such as injury, obstruction, crowding, infection, and 
extraction of deciduous or adjacent permanent teeth.  Demirjian (1978) likewise 
noted several reasons why mineralization is preferred over emergence.  He 
stated that tooth emergence is a transient event, timing this exact event is 
difficult, and emergence can be easily disturbed by environmental factors such as 
infection or crowding.  He also stated that the emergence data is limited to the 
ages at which teeth actually emerge; for the primary dentition is 6 to 30 months 
of age and for the permanent dentition is 6 to 12 years of age. 
The mineralization of a tooth is a continuous process that begins at the 
cusp tip and continues down the formative tooth in a regimented fashion.  
Mineralization of the root never begins until crown formation is complete.  The 
last stage of tooth development is closure of the root apex.  This continual 
mineralization process can be divided into distinguishable stages.  Table 3 shows 
several systems that have been developed to separate this continuous process 
into discrete, identifiable stages to facilitate study (Gleiser and Hunt 1955; Garn 
et al. 1958; Nolla 1960; Fanning 1961; Moorrees et al. 1963; Demirjian et al. 1973). 
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Table 3.  Comparative table of mineralization stages used by different authors. 
 
 Gleiser  Garn    Moorrees  Demirjian 
 & Hunt et al. Nolla  Fanning et al. et al. 
 (1955) (1958) (1960) (1961) (1963) (1973) 
Presence of crypt I - 1 O - - 
Cusp formation II 1 2 C1 1 A 
Cusp coalescence III - - CCO 2 - 
Cusp outline IV - - COC 3 B 
Crown 1/3 - - 3 - - - 
Crown 1/2 V - - Cr1/2 4 C 
Crown 2/3 VI - 4 Cr2/3 - - 
Crown 3/4 - - 5 - 5 - 
Crown complete VII - 6 CrC 6 D 
Initial root VIII 2 - R1 7 - 
Initial cleft VIII A - - Cl1 8 - 
Cleft enlarging VIII B - - Cle 8 - 
Root 1/4 IX - - R1/4 9 E 
Root 1/3 X - 7 R1/3 - - 
Root 1/2 XI - - R1/2 10 - 
Root 2/3 XII - 8 R2/3 - F 
Root 3/4 XIII - - R3/4 11 - 
Root complete XIV - 9 RC 12 G 
Apex 1/4 closed - - - A1/4 - - 
Apex 1/2 closed - - - A1/2 13 - 
Apex 3/4 closed - - - A3/4 - - 
A pex closed XV 3 10 AC 14 H  
 
Source: Demirjian A.  Dentition.  In:  Falkner F, Tanner JM, editors. Human 
growth 2.  postnatal growth.  New York and London:  Plenum Press, 
1978, p 412-44. 
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 Gleiser and Hunt (1955) made drawings of the outlines of the permanent 
mandibular first molar of the serial radiographs of 50 children (25 boys and 25 
girls) that were taken at three month intervals from birth to 18 months, then at 
six month intervals from 18 months to 10 years of age.  They chose 15 stages of 
mineralization (Table 4) from these drawings.  The scoring of mineralization for 
individual teeth was accomplished by selection of the “closest” grade from the 16 
possible choices. 
Garn et al. (1958) used three mineralization stages and two stages of tooth 
eruption to evaluate sex differences in the formation of the mandibular premolar 
and molar teeth.  The three stages of tooth mineralization were (1) initial 
mineralization, (2) beginning root mineralization, and (3) apical closure.  The two 
stages of eruption were (1) beginning of alveolar eruption and (2) attainment of 
the occlusal level. 
Nolla (1960) used a scale developed by Pinney (1939) and modified it for 
the study of tooth mineralization using serial radiographs of a group of 50 
children.  Her scale was comprised of a set of drawings of ten stages of 
mineralization for each permanent tooth type.  The radiographic image was 
matched with the comparative drawing, which had a corresponding stage 
valued from one to ten (Table 5).  If a tooth was between stages Nolla’s solution 
was to use the lower stage and add 0.5 to the value assigned to the tooth.  If a 
tooth was slightly less, then 0.3 was subtracted from the closest corresponding  
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Table 4.  Definitions of the 15 stages of tooth formation used by Gleiser and Hunt 
(1955) to grade the mineralization of the mandibular first permanent molar. 
 
 Stage Definition 
 I no calcification:  crypt formed but no mineralization yet 
 II centers of calcification visible:  amelogenesis has begun on the 
individual cusp tips 
 III coalescence of centers:  centers of calcification are merged 
 IV cusp outline complete:  the coronal outline is mineralized 
 V 1/2 crown:  amelogenesis is half way to cervical margin 
 VI 2/3 crown completed 
 VII crown completed:  morphologically, the crown has mineralized 
but root formation has not begun 
 VIII minimal root formation:  there is just a trace of root radiopacity 
below the crown outline 
 VIII A cleft minimal: interradicular mineralization is evident 
 VIII B cleft rapidly enlarging:  significant mineralization evident in the 
interradicular area but root not 1/4 formed 
 IX 1/4 root:  the radiographic morphology of the root is 1/4 of its 
projected final size 
 X 1/3 root completed 
 XI 1/2 root completed 
 XII 2/3 root completed 
 XIII 3/4 root completed 
 XIV divergent root canal walls:  full root length achieved but walls 
of root canal have not yet converged terminally 
 XV convergent root canal walls:  walls of root canal converged 
terminally and roots appear mature 
 
Source:  Gleiser I, Hunt EE Jr.  The permanent mandibular first molar:  its 
calcification, eruption and decay.  Am J Phys Anthropol 1955;13:253-83. 
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Table 5.  Definitions of the ten stages of tooth formation used by Nolla (1960) to 
grade the mineralization of all tooth types. 
 
 Stage Definition 
 
 0 absence of crypt:  no sign of tooth development is apparent 
 
 1 presence of crypt:  crypt is formed but no mineralization has 
begun 
 
 2 initial calcification:  amelogenesis has begun on the cusp tips 
 
 3 one-third of crown completed:  amelogenesis is 1/3 the way to 
the cervical margin 
 
 4 two-thirds of crown completed 
 
 5 crown almost completed:  morphologically, the crown has 
mineralized to just short of the cervical margin 
 
 6 crown completed:  morphologically, the crown has mineralized 
but root formation has not begun 
 
 7 one-third of root completed:  the radiographic morphology of 
the root is 1/3 of its projected final size 
 
 8 two-thirds of root completed 
 
 9 root almost completed:  full root length has been achieved but 
apex is still open 
 
 10 root completed:  apical end of root completed and apex is 
closed 
 
Source: Nolla CM.  The development of the permanent teeth.  J Dent Child 
1960;27:254-66. 
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 grade.  If a tooth was slightly more developed that the grade indicated, 0.2 was 
added to the grade indicated.  The thought was to have a more accurate 
description of mineralization stage than just selection the closest full grade. 
 Fanning (1961) adapted the grading scheme of Gleiser and Hunt (1955) in 
her longitudinal study of tooth formation.  Three apical stages were added for 
greater precision, to give a total of 20 gradable stages of tooth development 
(Table 6).  The mesial and distal roots of molars were studied separately.  
Moorrees et al. (1963) used the schemes of Fanning (1961) to develop a 13-
grade scale for single-rooted teeth and 14-grade scale for multi-rooted teeth (Fig. 
4).  These latest grading schemes by Moorrees et al. are a collaboration of 
information and conform with slight modifications to those used by other 
investigators (Gleiser and Hunt 1955; Demisch and Wartmann 1956; Garn et al. 
1958; Nolla 1960; Fanning 1961).  Normative data on the mineralization timing of 
ten permanent teeth, by sex, were calculated using these scales.  Their method of 
estimating dental age was to score all of the available teeth and then use the 
graphs provided in their publication to obtain the expected chronological age 
from each stage of each tooth.  The dental age for an individual was obtained by 
averaging across the scorable teeth.  There was no weighting or selection of the 
tooth scores.  Recently, Harris and Buck (2002) have published tables of values 
measured from Moorrees’ graphs, which expedites calculating dental ages. 
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Table 6.  Definitions of the 20 stages of tooth formation used by Fanning (1961) 
to grade the mineralization of the mandibular canines, premolars and molars. 
 
 Stage Definition 
 O no calcification:  crypt formed but no mineralization yet 
 C1 centers of calcification visible:  amelogenesis has begun on the 
individual cusp tips 
 CCO coalescence of centers:  centers of calcification are merged 
 COC cusp outline complete:  the coronal outline is mineralized 
 Cr1/2 1/2 crown:  amelogenesis is half way to cervical margin 
 Cr2/3 2/3 crown completed 
 CrC crown completed:  morphologically, the crown has mineralized 
but root formation has not begun 
 R1 minimal root formation:  there is just a trace of root radiopacity 
below the crown outline 
 Cl1 cleft minimal: interradicular mineralization is evident 
 Cle cleft rapidly enlarging:  significant mineralization evident in the 
interradicular area but root not 1/4 formed 
 R1/4 1/4 root:  the radiographic morphology of the root is 1/4 of its 
projected final size 
 R1/3 1/3 root completed 
 R1/2 1/2 root completed 
 R2/3 2/3 root completed 
 R3/4 3/4 root completed 
 RC divergent root canal walls:  full root length achieved but walls 
of root canal have not yet converged terminally 
 A1/4 1/4 apex closed 
 A1/2 1/2 apex closed 
 A3/4 3/4 apex closed 
 AC convergent root canal walls:  walls of root canal converged 
terminally and roots appear mature 
 
Source:  Fanning EA.  A longitudinal study of tooth formation and root 
resorption.  NZ Dent J 1961;57:202-17. 
 
41




	





	
	


	







 


 

 
 


 


















 


















 


 

 
 


 


















 























 !

!
"

#

$




%
	
 

&$
#

$
 

&
$
$
#

	


'
$

	
(


)
*






	
	
	 

	
+
(
	$
,

-
!
.
#





$
 

&


	 

/

$

$
$
#
	



$
 

&


(
$
/

$

$
$
#
$#


&
&

	


)
	
 
$#



$

	
&



&$
	
$

$
	
&

$#


(
$
/

$




!
"
(


0








	
	
	 
1

+
(
	$
2
!1
1
!

 
3


$
	

&&


$

	
$
 

	
$
	
4


	
	
$

$
$
#!
2
5
	
$



6

0

/

!
4 2
 Demirjian et al. (1973) devised a different, statistically more sophisticated 
method of evaluating dental age.  Demirjian et al. scored just the mandibular 
seven permanent teeth (omitting the third molar) because information from the 
maxillary teeth is redundant and they often are difficult to evaluate because of 
radiologically superimposed bony structures.  In this new assessment, a letter 
grade is assigned to each tooth from A to H, in relation to one, two or three 
written criteria (Fig. 5).  If only one criterion was given for a particular stage, it 
must be met for the stage to be counted as attained; if two criteria were given, at 
least the first one has to be met; if three were given, at least the first two have to 
be met for the stage to be counted.  To aid in the scoring, diagrams and pictures 
of radiographs corresponding to the eight stages were used.  Letter scores were 
converted into self-weighted, sex-specific numerical scores that were then 
summed to give a total maturity score.  The dental age could be calculated by 
converting the score using a table of standards. 
 
Stages of Tooth Formation Seen Radiographically 
 The first radiographic evidence of tooth formation is the translucent 
follicle situated at or near the alveolar bone crest, which increases in size and 
becomes circular in shape.  This image on the radiograph was not assigned a 
Moorrees et al. 1-14 grade but an arbitrary grade assigned for crypt formation, 
but no crown formation.  The follicle continues to enlarge while the crown  
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 commences formation (Fanning 1961).  Figures 6 and 7 are examples of the 13 
and 14 stages seen radiographically.  Stage one is termed initial cusp formation 
and defined as when amelogenesis has begun on the individual cusp tips.  Stage 
two is termed coalescence of cusp and it is defined as when the centers of 
mineralization are merged but the border is not everywhere radio-opaque.  Stage 
three is termed cusp outline complete and it is when the coronal outline of the 
tooth is mineralized.  Stage four is termed crown one-half formed and it is when 
amelogenesis has proceeded half way to the crown-root as judged from 
morphology of the radio-opaque portion.  The fifth stage is when one-half of the 
crown has completed mineralization.  Stage six is termed crown complete and it 
is when morphologically, all the crown has mineralized but root formation has 
not begun.  Stage seven is termed initial root formation and it is when there is a 
trace of root radiopacity below the crown outline.  The next stage is only in 
multi-rooted teeth and it is defined as initial cleft formation and it is when 
mineralization is evident in the interradicular area.  Stage eight in single rooted 
teeth and nine in multi-rooted teeth is termed root length one-forth and it is 
when the radiographic morphology of the root is one-forth its projected final 
size.  As the root lengthens the stages progress to one-half (stages 9 and 10 for 
single and multi-rooted teeth, respectively), three-quarters (stages 10 and 11 for 
single and multi-rooted teeth, respectively), and then root completion (stages 11 
and 12 for single and multi-rooted teeth, respectively).  The last two stages are  
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 apex half closed and apical closure complete.  The apex half closed is seen of the 
radiograph as the lateral borders for the root tip becomes convex rather than 
tapered as earlier (stages 12 and 13 for single and multi-rooted teeth, 
respectively).  The final stage is apical closure complete and it is when the size of 
the apical foramen is reduced to its mature size (stages 13 and 14 for single and 
multi-rooted teeth, respectively) (Harris and McKee 1990). 
 
Left-Right Asymmetry and Delayed Dental Development 
It has been shown that children with a cleft lip and palate (CLP) are at risk 
for reduced size (Hunter and Dijkman 1977; Cooper, Harding and Krogman 
1979; Jensen, Dahl, and Kreiborg 1983; Bowers et al. 1987), slower growth 
(Menius, Largent and Vincent 1966; Bailit, Doykos and Swanson 1968; Ranta 
1984), and other postnatal deficiencies (Ross 1965; Dahl 1970; Ross and Johnston 
1972).  It is thought that the reduced growth is due to a debilitating 
environmental factors in which these children experience feeding difficulties, 
contract upper respiratory infections and undergo repeated hospitalizations for 
lip and palate surgeries (Cox 1960; Ross 1965; Drillien, Ingram and Wilkinson 
1966; Hunter and Dijkman 1977).  Harris and Hullings’ (1990) study support the 
aforementioned statements, in that the teeth that begin to form in utero do not 
show any signs of delayed or altered dental development.  It is a common 
clinical perception that teeth of children with CLP are slower to form and erupt.  
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 The stresses of CLP can also increase left-right asymmetry of the developing 
dentition (Harris and Hullings 1990; Ranta 1973a,b).  Left-right asymmetry and 
delayed dental development were noted across all tooth types and throughout 
both arcades (Harris and Hullings 1990; Ranta 1973a,b).  These dental sequelae 
yield insights into the developmental process of children with CLP and tooth 
formation constitutes a sensitive measure of overall health (Niswander 1963; 
Bailit 1975). 
It is common knowledge that ALL itself is a debilitating disease and the 
stresses placed on the systems of the body are immense.  Due to the nature of the 
disease and the quest to expeditiously diagnose and begin treatment yields little 
information on its effects and more specifically its effects on the dentition.  
Halton et al. (1995) have studied mineral homeostasis and bone mass at diagnosis 
in children with ALL before chemotherapy treatment begins.  They found that 
most children with ALL have alterations in bone metabolism and bone mass 
when first seen.  Abnormally low circulating 1,25(OH) sub 2 D3 levels associated 
with hypercalciuria; may result in calcium and phosphate depletion, limiting 
bone mineralization.  Presently, there seems to be no research on the effect of 
ALL on tooth mineralization in the absence of treatment to cure the disease.  
Tooth mineralization is a relatively slow process compared to the quick onset of 
ALL.  An expedited diagnosis followed by swift induction into treatment is 
desired, which leaves virtually no time to study the effects of ALL itself on the 
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 dental development and mineralization.  Inferring from previous literature on 
bone mineralization we conclude that dental mineralization is also limited or 
delayed.  Foote (1928:2) helps to reveal the link between bone and tooth 
mineralization with a passage from his book: 
We are accustomed to think that dentinal substance was produced 
by one cell, the odontoblast, enamel substance by another cell, the 
ameloblast, and bone substance, by still another cell, the osteoblast, 
and we have erected impassable barriers between them, but the fact 
remains, however, that all cells of any individual were derived 
from one cell which possessed the original endowment of 
protoplasm and it only requires the presence of certain 
environmental conditions to cause the descendants of that cell to 
exercise their original prerogatives.  Teeth and bond have 
something in common which is fundamental and we have reason 
for thinking that, since bone shows variations during its long 
biological history, teeth may also present similar analogous 
variations. 
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 CHAPTER III 
 
MATERIALS AND METHODS 
 
Sample Selection 
This was a retrospective mixed longitudinal study of panoramic 
radiographs taken by pediatric dentists for diagnostic purposes.  The three 
selection criteria consisted of:  (1) The children were enrolled at St. Jude Research 
Hospital, Memphis, Tennessee between August 12, 1982 and March 24, 2000 with 
a diagnosis of ALL.  (2) Patients needed to have at least two panoramic 
radiographs separated by at least 22 months.  (3) The children were between 4 
and 10 years of age at the time of the first radiograph.  Institutional Review 
Board approval was obtained and the examiner was certified to access the 
records and obtain all the necessary data. 
 
Sample Distribution 
ALL is characterized by childhood onset, as is seen in the present sample.  
There were 72 subjects in the present study (31 girls and 41 boys).  Mean 
chronological age at diagnosis of ALL was 6.76 years in both sexes (overall sd =  
2.11 years), with a range of 3.1 to 10.5 years. 
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 Panoramic radiographs (Graber 1967) were taken of these children by the 
staff pediatric dentist as indicated for routine restorative dental work.  As such, 
panoramic radiographs were not taken at any set interval, and the number of 
radiographs varied among the children.  A total of 190 panoramic radiographs 
were available for the 72 children studied here.  The distribution of radiographs 
was:  6 children had just one radiograph; 33 children had 2 radiographs; 20 
children had 3 radiographs; 9 children had 4 radiographs; 2 children had 5 
radiographs; and 2 children had 6 radiographs.  There was a problem in the 
results of the records search using the selected criteria—6 of the children that 
were initially selected had only one radiograph available, however, they were 
included in the study. 
At the time of diagnosis of ALL, patients are assigned to one of three risk 
categories based on the age at diagnosis, sex, type of leukemia, and prognosis.  
Cranial irradiation may be given to patients either with higher-risk leukemia or 
CNS leukemia at the time of diagnosis in addition to chemotherapy.  Moreover, 
patients who did not respond favorably to the chemotherapy may have had 
irradiation added to their protocol.  There were 25 of the 72 patients whose 
treatment protocol included the addition of radiation therapy. 
Four of the 72 children were deceased from ALL when this study was 
performed. 
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 Scoring Methods 
The dental maturation of every tooth on each radiograph was examined 
and subsequently scored for the degree of crown-root formation.  There were 
two types of panoramic radiographs examined:  143 conventional radiographs 
and 47 digital radiographs.  The conventional radiographs were examined using 
a light box with no magnification.  The digital radiographs were examined using 
the imaging software provided by St. Jude Research Hospital. 
The Moorrees, Fanning and Hunt (1963) grading schemes were used in 
this study (Fig. 4).  Single-rooted teeth are scored on a 13-grade scheme.  Multi-
rooted teeth are scored on a 14-grade scheme.  The single difference between 
these two schemes is the addition of “cleft formation” for multi-rooted teeth.  In 
our experience, this system provides finer discrimination than simpler 
morphological methods (Demirjian and Goldstein 1976), but the grades are not 
so numerous that confusion between adjacent grades is likely.  Short descriptions 
of the grades are provided in Table 7.  When the tooth development appears to 
fall between grades, the highest grade actually achieved was scored as suggested 
by Dahlberg and Menegaz-Bock (1958).  All 32 permanent teeth were scored, so 
far as possible.  Reasons for missing data include overlapping images of teeth, 
missing teeth, severely angulated or malpositioned teeth, unformed teeth, teeth 
diagnosis as being affected by irradiation, or underexposure or overexposure of 
the film. 
53
Table 7. Definitions of the tooth formation stages. 
 
Single-
Rooted 
Teeth 
 
Definitions 
Multi-
Rooted 
Teeth 
1 Initial cusp formation: amelogenesis has begun 
on the individual cusp tips. 
1 
 
2 
Coalescence of cusps: centers of mineralization 
are merged but the border is not everywhere 
radiodense 
2 
3 Cusp outline complete: the coronal outline of 
the tooth is mineralized. 
3 
 
4 
Crown 1/2 formed: amelogenesis has 
proceeded half way to the crown-root as 
judged from morphology of the radiodense 
portion 
4 
5 Crown 3/4 complete 5 
 
6 
Crown complete: morphologically, all the 
crown has mineralized but root formation has 
not begun. 
6 
7 Initial root formation: there is a trace of root 
radiopacity below the crown outline. 
7 
--- Initial cleft formation: mineralization is evident 
in the interradicular area. 
8 
8 Root length 1/4: the radiographic morphology 
of the root is 1/4 its projected final size. 
9 
9 Root length 1/2 complete. 10 
10 Root length 3/4 complete. 11 
11 Root length complete. 12 
12 Apex half closed: the lateral borders of the root 
tip become convex rather than tapered as 
earlier. 
13 
13 Apical closure complete: size of the apical 
foramen is reduced to its mature size. 
14 
Source:  Harris EF, McKee JH.  Tooth mineralization standards for blacks 
and whites from the middle southern United States.  J Forensic 
Sci 1990;35:859-72. 
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 Comparisons were made to the sex-specific American white standards of 
Harris and McKee (1990).  These data are based on children between the ages of 
about 3 and 13 years of age, which captures most intervals of permanent tooth 
formation.  It does not, however, include the later formative stages of the third 
molar, so the standards were supplemented with data on mandibular third 
molars from Harris (1998).  Dental age was computed for each permanent tooth 
that had not completed root apexification using the following method:  (1) The 
stage of a tooth’s formation was related along the 13-grade scheme for single-
rooted teeth or the 14-grade scheme for multi-rooted teeth.  (2) That grade was 
used to find the average chronological age (from the published standards) at 
which normal children of the appropriate sex achieved stage.  This was termed 
the observed age.  (3) The child’s chronological age was used to find the stage of 
tooth formation expected if he or she were growing at a normal rate.  The 
corresponding age (from the published norms) for that stage of formation was 
used as the expected age.  (4) The difference between observed and expected age 
is, then, the extent to which ALL and subsequent treatment affect growth.  This 
was done on a tooth-specific basis and then the results for all formative teeth 
were used to calculate the average, overall dental age. 
Tooth crown and root mineralization is a continuous process beginning 
with mineralization of the cusp tips and progressing to root apex closure 
(Bhaskar 1991).  This continuum can be artificially partitioned into several 
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 discrete “grades” in order to make it feasible to visually assess the degree of 
tooth completion.  The grades—such as those devised by Nolla (1960), Moorrees 
et al. (1963), and Nielsen and Ravn (1976)—are ordinal-scale data; the intervals 
between the grades are unequal, but each grade of formation is morphologically 
discrete from others.  In terms of chronological ages, there typically is about a 
one-year difference between one grade of formation and the next.  Step 3 in the 
method of calculating dental age was used to account for these “jumps” in the 
data as tooth formation ages “lurch” from one stage to the next—rather than 
progressing smoothly and continuously if the data were ratio-scale.  
 
Assessment of Intraobserver Reliability 
The value of the data collected in this study depends on the ability of the 
examiner to accurately distinguish among the grades of mineralization 
visualized for each tooth on the panoramic radiographs.  Care was taken to 
ensure that the single examiner was experienced with the definitions of each 
grade and how to properly identify the grade obtained on the radiographs.  
Levesque and Demirjian (1980) reported on the inter-examiner variation in rating 
dental formation from radiographs.  Their finding indicated that there was an 
inter-examiner reliability of 80% for molars and incisors; the reliability was lower 
for premolars (75%) and canines (70%).  There is little research in the area of 
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 intra-examiner reliability to date, but some information is provided by Fanning 
(1961), Grøn (1962) and Harris and McKee (1990). 
According to Fanning (1961:206-7) in her longitudinal study of tooth 
formation and root resorption certain stages could be graded with reasonable 
accuracy.  Of note, her elaborate system contained more grades than used in the 
present study, and, indeed, Fanning deleted the more ambiguous grades to 
arrive at the grading system used here (Table 7). 
Although the interpretation of dental development from 
radiographs is subjective, certain stages such as follicle and early 
crown formation, crown completion, initial root formation, and its 
apical closure could be evaluated accurately and served as a check 
in the assessment.  Since the entire chronology was recorded in the 
longitudinal study, the stages of tooth formation or root resorption 
could be assigned with reasonable accuracy.  Comparisons of 
developmental ratings with earlier and later films of the same tooth 
assisted in the assessment of the intermediate stages of crown and 
root formation that were the most difficult to evaluate. 
Test for accuracy in assessment were made by independent ratings 
of incisor and premolar teeth in ten males.  In 972 assessments, 
complete agreement occurred in 73% and disagreement of no more 
than one full stage in 27%. 
 
It can be concluded that one examiner can accurately assign the correct 
stages of tooth mineralization with adequate accuracy.  It should be noted that 
only teeth imaged with good radiographic quality, not obstructed by 
superimposed bony structures or malpositioned enable the observer to obtain an 
accurate grading of the correct stage of mineralization. 
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 In Grøn’s study (1962), 60 intraoral radiographs representing different 
teeth at different stages of formation were rated independently by two other 
observers who had no previous experience in assessing stages of root formation.  
Disagreement between these observers was never greater than one stage.  
Differences occurred in 2 out of 25 instances, except for the maxillary central 
incisor, where differences occurred in 50% of the double determinations.  The 
evaluation of tooth development in this cross-sectional study was critical because 
the majority of the teeth had attained either one-half or three-quarters of their 
root length.  In the absence of longitudinal records facilitating assessment, a test 
was made to determine the reliability of distinguishing between two stages of 
root development that were not far apart.  Therefore, the formation of all teeth 
studied was rated twice by the author with an interval of at least 3 months.  In 
approximately 10% of the two assessments the differences in the total material 
(omitting central incisors) never exceeded one stage.  However, for both the 
maxillary and the mandibular central incisors, there was agreement in only 75% 
of the repeated assessments, but with the differences in assessment being still 
only one stage apart. 
Harris and McKee (1990) reported a 96% agreement in double 
determinations on 80 cases in their study, with no difference exceeding one stage. 
The present study is in agreement with these previous reports of high 
repeatability.  In 95% of the cases (8/160 teeth), the two assessments were in 
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 agreement, and of those eight, four were reported to be unscorable due to poor 
image quality, on the second assessment. 
 
Appropriateness of Tooth Formation Standards 
It is necessary to compare the tempos of crown-root formation in children 
with ALL against normative growing children in order to assess whether 
treatment impacts the rates of dental maturation.  This creates some issues 
because (A) these children with ALL are of numerous ethnic and racial 
backgrounds and (B) this study is retrospective, so there is no opportunity to 
match children who are disease-free to those with ALL.  Ideally, each participant 
with ALL could be matched with one or more siblings examined at the same 
chronological age (and adjusted for sex difference in growth tempos; (Demirjian 
1978).  This would match the children with ALL for race, ethnic differences and, 
importantly, make an effort at controlling for familial differences in the tempos 
of dental maturation.  It also would match the children for cultural and 
socioeconomic parameters. 
This desired design was not possible and, in fact, there are strikingly few 
“standards” of normative tooth formation available in the literature, and almost 
all of them are based on the development of caucasian population samples (e.g., 
Moorrees et al. 1963; Harris and McKee 1990; Haavikko 1974; Demirjian et al. 
1973).  Of these, the data from Harris and McKee (1990) seem the most 
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 appropriate inasmuch as (A) they are the most recent (from a cohort that grew 
up in the 1980s) and closest temporally to the subjects with ALL;  (B) they were 
collected from a broad geographic region in the Southern United States, which 
may make them somewhat more generalized than studies of more localized 
groups;  (C) they reflect a broader range of socioeconomic strata than some other 
previously published studies (e.g., Moorrees et al. 1963); and (D) we had access to 
the raw data for statistical manipulations.  The Harris-McKee standards probably 
are far from a perfect fit, especially for the several children with ALL from 
foreign countries, but they seem to constitute the best-available standards.  The 
subset of American caucasian standards was used for all comparisons (Harris 
and McKee also reported data for American Blacks). 
It is important to recognize that tempos of development vary with a 
group’s stages of growth (Nykanen et al. 1998; Farah et al. 1999; Olze et al. 2003; 
Liversidge 1999; Liversidge et al. 1999; Teivens and Mornstad 2001).  It is unlikely 
that the growth tempos of two groups will simply parallel one another 
throughout childhood and adolescence.  For present purposes, comparisons are 
limited to the start of treatment.  The broad question is whether the Harris-
McKee standards for dental development are appropriate to the manner in which 
the sample with ALL matured?  Once treatment for ALL was initiated, however, 
it was anticipated that the slowing effects would significantly impact the 
pretreatment tempos.  At the start of treatment, the assumption is that DA-CA 
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 would be centered on zero.  This assumes that ALL in itself does not alter the 
tempo of dental maturation.  Analogously, there is some evidence that stature is 
somewhat greater in children with ALL at the time of diagnosis.  Broomhall et al. 
(1983) performed a retrospective study of 236 children with ALL from the United 
Kingdom and found them to be significantly taller than their reference standards.  
There was no difference between the sexes, nor was there a difference between 
those older and younger than the median age.  Griffin and Wadsworth (1980) 
also found the height at diagnosis to be greater than the reference sample in their 
study of 65 patients diagnosed with ALL.  In contrast, other studies found no 
difference in height between children with ALL at the time of diagnosis and 
normal children (e.g., Bessho 1986; Holm e. al. 1994) 
Table 8 lists the results of univariate one-sample t-tests of whether DA-CA 
differed significantly from zero.  That is, if the Harris-McKee (1990) standards are 
representative of the manner in which the children with ALL were growing, then 
the distribution of DA-CA would be centered on zero.  Rather arbitrarily, those 
dental examinations (panoramic radiographs) taken within 1.0 year of the onset 
of treatment for ALL were assessed.  The two competing considerations with this 
analysis are (1) one would like to increase sample sizes (and, thus, statistical 
power) by including more scores of tooth development but  
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Table 8. One-sample t-tests of DA-CA based on tooth formation stages of 
patients within 1.0 year of diagnosis for ALL.1 
 
 Tooth Mean SD SEM n t-test Prob > |t| 
Maxilla 
 C -0.31 1.06 0.19 31 -1.64 0.1096 
 P1 -0.95 1.34 0.95 2 -1.00 (0.5000) 
 P2 -1.07 0.15 0.09 3 -12.10 (0.0068) 
 M1 -0.23 0.98 0.16 36 -1.39 0.1725 
 M2 0.28 1.00 0.14 48 1.99 0.0523 
 M3 1.13 0.84 0.42 4 2.68 (0.0748) 
Mandible 
 C -0.45 1.14 0.17 47 -2.73 0.0089 
 P1 0.36 1.04 0.14 52 2.49 0.0159 
 P2 0.36 0.97 0.14 46 2.51 0.0156 
 M1 -0.40 1.03 0.15 44 -2.57 0.0137 
 M2 0.21 1.10 0.16 46 1.31 0.1958 
 M3 1.13 0.90 0.29 10 3.96 0.0033 
Arithmetic Average, All Teeth 
All teeth 0.05 0.76 0.11 52 0.50 0.6200 
1Just teeth in the right jaws were used here. P-values based on unreliably 
small sample sizes are listed in parentheses. 
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 (2) there is some unknown point after the onset of treatment at which the 
slowing effects of treatment influence tooth development.  A cut-off of 1.0 year 
seemed to be reasonable (other intervals were tested with comparable results). 
Ignoring the three maxillary teeth with unreliably small sample sizes (< 5), 
it is striking that several differences are statistically significant (and two others 
are suggestive, with 0.10 > P > 0.05).  Of note, too, the sign of the DA-CA differs 
among the tooth types.  A negative value for DA-CA means that DA is less 
mature than expected from the Harris-McKee standards.  Conversely, a positive 
DA-CA value indicates that the dental age of the tooth is advanced compared to 
the Harris-McKee standards developed from American whites. 
This mix of positive and negative values is not surprising, but it means 
that the samples of children with ALL examined here exhibits a different pattern 
of tooth development than in the Harris-McKee standards (see, e.g., Tompkins 
1996a,b).  The significant differences for at least 5 of the 12 comparisons (Table 8) 
also is of concern, particularly since the DA-CA differences range up to one year 
(for mandibular M3) at the start of treatment. 
Alternatively, there is no solution to the observed discrepancies, especially 
the mixture of positive and negative differences among the tooth-specific tempos 
of development.  In fact, we explored the use of other dental “standards”—
notably the works of Moorrees et al. (1963) and of Demirjian et al. (1973)—but the 
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 DA-CA “discrepancies” were not resolved:  Changing the standards merely 
altered the mixture of positive and negative differences. 
Another solution might be to numerically adjust the data so, at least at the 
start of treatment, the two samples (the children with ALL and the published 
norms) would be comparable.  For instance, mean DA-CA for the mandibular 
canine is –0.46 years.  One approach would be to adjust the dental age of all 
mandibular canine scores by adding 0.46 years, so the resulting mean would be 
zero.  There are at least two reasons not to do this.  One, the data in Table 8 are 
composites of different children with teeth at different stages of formation.  
There is no practical way to adjust the mean ages—let alone the variabilities—of 
all stages of all teeth.  Secondly, the results in Table 8 are in effect a snap-shot of 
the tempos of tooth development right after the age at diagnosis.  There is no 
reason to suppose that the relation between the tempos of tooth formation 
between the two samples remained at all parallel with one another with 
advancing age. 
Consequently, while noting the several statistically significant differences 
at the start of treatment for ALL, we made no adjustment in the data.  Of note, 
the tooth-specific differences nullify one another:  Inspection of DA-CA averaged 
over all scorable teeth (Table 8) shows that dental age for the individual is 
insignificantly different vis-à-vis the Harris-McKee standards. 
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 Statistical Methods 
Data were compiled using Microsoft Excel (Microsoft Corporation, 
Redmond, WA).  Data included the child’s sex, birthdate, the age at diagnosis of 
ALL (which we used as being the age at the onset of treatment), and the date of 
each panoramic radiograph.  Information also was available on the dates, if any, 
and dosages of irradiation received.  The tooth formation scores from each 
panoramic radiograph also were entered.  A separate custom-written program 
was used to calculate the dental age of each tooth as described earlier, and these 
data were merged into the Excel file. 
Statistics all were generated using JMP version 5.0.02 (SAS Institute Inc., 
Cary, NC), which imports an Excel file directly. 
The data treated here are all parametric continuous variables, and the 
conventional parametric tests are described in most statistical textbooks (e.g., 
Winer et al. 1991; Sokal and Rohlf 1995).  The three major tests used here are (1) 
linear regression analysis, (2) factorial analysis of variance, and (3) Pearson 
product-moment correlation coefficients.  The nature of the data prevented the 
use of a repeated measure model to follow the progress of DA through the 
course of treatment.  Some use was made of a pairing-design t-test to test for 
intra-individual changes in DA-CA. 
All tests were two-tail, and the conventional level of statistical significance 
(alpha = 0.05) was used. 
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 CHAPTER IV 
 
RESULTS 
 
The dental age of each scorable permanent tooth was calculated using the 
American-white standards of Harris and McKee (1990).  As a preliminary, 
exploratory step, “average” dental age was calculated by (A) determining the 
difference between dental age and chronological age (DA-CA) for each tooth 
and, then, (B) taking the arithmetic average across all teeth.  A potential issue is 
that there is appreciable redundant information in this average dental age 
(Demirjian et al. 1973), but it provides a practical starting point for the analysis. 
Regressing DA-CA on chronological age (using all available panoramic 
examinations) produces the scattergram in Figure 8.  If dental age were 
unaffected by the treatment for ALL, the distribution of DA-CA would be 
centered on zero independent of chronological age.  Instead, there is a highly 
significant negative association between CA and DA-CA (b = -0.07; t = 2.91; P < 
0.0041) such that the older the individual, the more delayed DA is relative to CA.  
The effect is modest, however, explaining just 4% of the variance in DA-CA, and 
a geometric model did not improve the fit. 
The dependency between age and DA – CA also was tested by sex.  
Results for females (n = 76 films) were not significant (b = -0.02; t = 0.51; P =  
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Fig. 8. Scatterplot showing the negative linear dependency between
time in treatment and the degree of dental developmental delay,
measured as DA-CA. The plot is for all scorable teeth from all
radiographs of all children in this study treated for ALL.
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 0.6115).  In contrast, it can be seen that the data for the boys carried the sexes-
pooled analysis (above) to significant, since the regression coefficient is -0.13 (df 
= 113; t = 3.52; P = 0.0006).  In other words, for the boys, DA drops an average of 
0.13 years farther below CA for each year into treatment for ALL.  This 
depression cannot go on indefinitely because physiological age ultimately 
achieves maturity in all subjects, but during this interval up to about a decade 
after the onset of treatment, there is a progressively increasing depression of DA 
behind CA.  Test of a quadratic model for these males did not improve the 
model. 
 
Dental Age at Diagnosis 
 Our perspective in this study is that changes in dental age are iatrogenic 
responses to treatment, not to the disease itself.  A key measure in support of this 
is that dental age is age-appropriate (i.e., DA = CA, so DA – CA = 0) at the start of 
treatment.  None of these children have dental radiographs prior to diagnosis 
and the onset of treatment, at least in the records at St. Jude Children’s Hospital.  
Many were fairly young and probably had not yet had a routine pediatric dental 
radiograph.  We tested the assumption of DA = CA by selecting just those 
radiographs taken within a half-year of the onset of treatment.  There were 37 
radiographs, and we averaged DA – CA over all scorable teeth.  The average DA 
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 – CA was 0.004 years (sd = 0.767).  A one-sample t-test shows that there is no 
suggestion that DA is effected (t = 0.03; df = 36; P = 0.51). 
 For completeness, this test of DA = CA was repeated by sex.  There was no 
difference in DA – CA and the data for both sexes were insignificantly different 
from zero.  In sum, one can infer that neither sex was demonstrably affected by 
ALL in terms of dental development. 
 Similarly, the sample was partitioned into those who were treated (A) 
with chemotherapy alone versus (B) with chemotherapy plus cranial irradiation.  
Again, there was no difference between DA – CA at the onset of treatment, and 
both means were insignificantly different from zero at the start of treatment.  
This suggests that criteria other than DA are involved in determining which 
children received cranial irradiation. 
 In sum, it seems safe to conclude that ALL itself does not affect DA—at 
least not around the time of diagnosis of this acute disease.  Subsequently, the 
iatrogenic effects of treatment cannot be separated from any changes in DA – CA 
due to the disease per se. 
 
Individual Responses to Treatment 
In addition to the standard statistical treatment of these data, it is 
informative to inspect the responses of each child’s dental maturation to the 
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 stressor of treatment.  One perspective is that perusal of the data should both 
suggest and confirm the statistical relationships seen for the sample as a whole. 
There are two appendices of graphs at the end of this work.  Appendix I is 
a set of bivariate graphs, one for each child, plotting dental age against 
chronological age.  Each plot shows the chronological age at diagnosis for ALL, 
which is virtually coincident with the onset of chemotherapy.  The number of 
dental ages on a graph depends on how many radiographs were available for 
that child. 
Notice the isochron line on each graph, which is the line where CA and 
DA are coincident.  So, if a child’s DA is equal to his CA, dental age will be on 
the isochron line.  If DA falls behind CA as often happens because treatment 
depresses the tempo of dental maturation, then the symbol will be below the 
isochron line. 
The second set of graphs (Appendix II) presents the same dental ages in a 
complementary format.  Here, the difference between DA and CA (i.e., DA-CA) 
is plotted for each tooth.  Each graph presents the information collected from one 
child, and different symbols code for the panoramic radiograph readings, 
showing the child’s CA at each examination.  The typical graph shows that all of 
the tooth types respond roughly the same and that DA-CA becomes a more 
negative value the farther the child is from the onset of treatment. 
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 Left-Right Symmetry 
One supposes that treatment for ALL affects the dentition symmetrically.  
This seems true for those children treated with chemotherapy as well as those 
who also received radiation therapy.   
Tests for systematic asymmetry involved assessing DA-CA on a tooth-
specific basis using paired t-tests.  That is, for each tooth type, the left and right 
values for DA-CA were compared in a pairwise fashion.  A significant difference 
would indicate that a tooth type on one side of the jaw was preferentially at risk.  
Results are listed in Table 9.  Interest was on whether there was enough left-right 
difference in the data to warrant including measurements from both sides.  
Alternatively, one supposes that information on the left and right quadrants are 
so highly correlated that using both sides is redundant and duplicative. 
There are 12 comparisons because the maxillary and mandibular incisors 
were seldom scorable because they form early and their development is less 
effected by therapy.  Notice too that sample sizes (number of scorable pairs) tend 
to be small for the maxillary teeth.  This is because details of the tooth structures 
often are obscured by the complexity of the overlying bony structures. 
Of the 12 comparisons, only the maxillary canines achieved statistical 
significance, where some teeth on the left side were more severely affected (i.e., 
greater DA-CA) than on the corresponding right side.  We attribute little 
importance to this finding since it is an isolated finding and only marginally  
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 significant statistically (P = 0.03).  Moreover, inspection showed that the 
difference was due to just 3 cases out of the sample size of 95.  Consequently, we 
ignored the redundancy of the data on homologous left and right teeth.  The 
considerable redundancy in information also is shown by the results of 
calculating the correlation in DA-CA between homologous left and right teeth 
(Table 10).  All 12 correlations are positive and in excess of 0.9.  Subsequent 
analysis was therefore limited to the individual’s right side.  
 
Tooth Type and DA-CA 
Two related issues are described in this section.  First, it is of interest 
whether DA-CA calculated from the various tooth types are positively 
interrelated or, alternatively, different tooth types—that develop at different ages 
(Moorrees et al. 1963) and that exhibit different variabilities (Dahlberg 1965) —
exhibit largely independent responses to the stress of treatment for ALL.  The 
second, complementary issue is how labile the development of each tooth type 
may be to the stresses of ALL treatment.  That is, does ALL produce a statistically 
discernible response in DA-CA for each tooth type?  Alternatively, are some 
tooth types more resilient to these stresses such that the effects of treatment differ 
depending on which tooth type or set of teeth is examined? 
To address the first question regarding the similarities of tooth formation 
to the stress of ALL, Pearson product-moment correlation coefficients were  
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Table 10.  Pearson product-moment correlation coefficients 
between DA-CA between homologous left and right teeth. 
 
 Right Left Correlation 
 Variable Variable Coefficent n P-Value 
 UC UC 0.9715 96 0.0000 
 UP1 UP1 1.0000 17 0.0000 
 UP2 UP2 0.9739 21 0.0000 
 UM1 UM1 0.9886 116 0.0000 
 UM2 UM2 0.9802 157 0.0000 
 UM3 UM3 0.9439 40 0.0000 
 
 LC LC 0.9708 156 0.0000 
 LP1 LP1 0.9825 167 0.0000 
 LP2 LP2 0.9766 160 0.0000 
 LM1 LM1 0.9888 142 0.0000 
 LM2 LM2 0.9948 171 0.0000 
 LM3 LM3 0.9719 48 0.0000 
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 calculated among all teeth on the right side of the dental arches.  There are 12 
tooth types because the early-forming incisors were omitted.  The correlations 
were computed in a pairwise fashion to maximize sample sizes.  Results (Table 
11) show that all of the correlations are positive and the majority are significant 
statistically (P < 0.05).  Those associations that are not significant seem to be tied 
to small sample sizes; this always involves a maxillary tooth, where sample sizes 
are compromised by difficulties in viewing the tooth because of overlying bony 
structures.  Taking the small sample sizes into account, there is no evidence that 
the sign or the magnitude of the correlations differs among the tooth types.  
Keeping in mind that different teeth undergo crown-root mineralization at 
different ages, there does not seem to be any differences in the strengths of the 
associations by tooth type. 
Results of the complementary issue are shown in Table 12.  Here the 
question is whether each of the 12 tooth types (i.e., examining permanent teeth 
just on the right side of the mouth and omitting the incisors) exhibits a 
statistically significant association between (A) time in treatment for ALL and (B) 
the variable DA-CA.  Treatment for ALL uses powerful chemotherapy with or 
without cranial irradiation.  This is a substantial stressor to all growth processes.  
On a tooth-by-tooth basis, is there evidence that treatment discernibly impacts 
the growth rate?  Here, the tempo of growth is measured by DA-CA.  There are  
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Table 11.  Pearson product-moment correlation coefficients among 
DA-CA of the 12 tooth types on the right side of the mouth. 
 
  Correlation 
Variable Variable Coefficient n P-Value 
 RUP1 RUC 0.644 16 0.0071 
 RUP2 RUC 0.609 19 0.0056 
 RUP2 RUP1 0.501 15 0.0571 
 RUM1 RUC 0.534 65 0.0000 
 RUM1 RUP1 0.540 12 0.0700 
 RUM1 RUP2 0.680 15 0.0053 
 RUM2 RUC 0.450 85 0.0000 
 RUM2 RUP1 0.563 15 0.0290 
 RUM2 RUP2 0.424 19 0.0704 
 RUM2 RUM1 0.461 111 0.0000 
 RUM3 RUC 0.222 24 0.2983 
 RUM3 RUP1 0.496 8 0.2116 
 RUM3 RUP2 0.454 8 0.2581 
 RUM3 RUM1 0.314 13 0.2956 
 RUM3 RUM2 0.400 30 0.0288 
 RLC RUC 0.618 86 0.0000 
 RLC RUP1 0.517 14 0.0581 
 RLC RUP2 0.339 19 0.1563 
 RLC RUM1 0.521 106 0.0000 
 RLC RUM2 0.397 140 0.0000 
 RLC RUM3 0.415 34 0.0146 
 RLP1 RUC 0.685 90 0.0000 
 RLP1 RUP1 0.809 17 0.0001 
 RLP1 RUP2 0.503 21 0.0201 
 RLP1 RUM1 0.505 112 0.0000 
 RLP1 RUM2 0.528 147 0.0000 
 RLP1 RUM3 0.398 33 0.0219 
 RLP1 RLC 0.600 150 0.0000 
 RLP2 RUC 0.567 84 0.0000 
 RLP2 RUP1 0.543 16 0.0299 
 RLP2 RUP2 0.774 19 0.0001 
 RLP2 RUM1 0.562 104 0.0000 
 RLP2 RUM2 0.576 140 0.0000 
Continued 
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Table 11. Continued. 
  Correlation 
Variable Variable Coefficient n P-Value 
 RLP2 RUM3 0.296 35 0.0845 
 RLP2 RLC 0.567 142 0.0000 
 RLP2 RLP1 0.835 155 0.0000 
 RLM1 RUC 0.591 76 0.0000 
 RLM1 RUP1 0.527 12 0.0784 
 RLM1 RUP2 0.608 15 0.0162 
 RLM1 RUM1 0.919 112 0.0000 
 RLM1 RUM2 0.423 126 0.0000 
 RLM1 RUM3 0.345 15 0.2086 
 RLM1 RLC 0.605 126 0.0000 
 RLM1 RLP1 0.578 137 0.0000 
 RLM1 RLP2 0.581 128 0.0000 
 RLM2 RUC 0.573 89 0.0000 
 RLM2 RUP1 0.471 15 0.0766 
 RLM2 RUP2 0.581 19 0.0090 
 RLM2 RUM1 0.567 106 0.0000 
 RLM2 RUM2 0.748 145 0.0000 
 RLM2 RUM3 0.391 38 0.0153 
 RLM2 RLC 0.398 145 0.0000 
 RLM2 RLP1 0.636 157 0.0000 
 RLM2 RLP2 0.646 155 0.0000 
 RLM2 RLM1 0.512 131 0.0000 
 RLM3 RUC 0.281 28 0.1475 
 RLM3 RUP1 0.690 6 0.1293 
 RLM3 RUP2 0.511 6 0.2998 
 RLM3 RUM1 0.243 17 0.3477 
 RLM3 RUM2 0.270 36 0.1112 
 RLM3 RUM3 0.800 33 0.0000 
 RLM3 RLC 0.309 36 0.0671 
 RLM3 RLP1 0.275 38 0.0951 
 RLM3 RLP2 0.193 42 0.2214 
 RLM3 RLM1 0.178 21 0.4461 
 RLM3 RLM2 0.442 46 0.0021 
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Table 12.  Resulting of testing for a statistically significant association 
between DA-CA against time in treatment on a tooth-specific basis. 
 
Bivariate fit of maxillary canine by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 4.91 3.93 0.0504 
Error 94 1.24 
C. Total 95 
 
Bivariate fit of maxillary first premolar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 1.14 1.00 0.3329 
Error 15 1.14 
C. Total 16 
 
Bivariate fit of maxillary second premolar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 0.00 0.00 0.9745 
Error 19 1.14 
C. Total 20 
 
Bivariate fit of maxillary first molar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 18.11 19.67 < 0.0001 
Error 114 0.92 
C. Total 115 
 
Bivariate fit of maxillary second molar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 1.43 1.27 0.2622 
Error 156 1.13 
C. Total 157 
Continued 
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Table 12. Continued 
 
Bivariate fit of maxillary third molar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 10.67 8.18 0.0068 
Error 39 1.30 
C. Total 40 
 
Bivariate fit of mandibular canine by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 17.94 13.57 0.0003 
Error 154 1.32 
C. Total 155 
 
Bivariate fit of mandibular first premolar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 16.15 12.94 0.0004 
Error 165 1.25 
C. Total 166 
 
Bivariate fit of mandibular second premolar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 19.71 17.18 < 0.0001 
Error 158 1.15 
C. Total 159 
 
Bivariate fit of mandibular first molar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 29.78 27.68 < 0.0001 
Error 140 1.08 
C. Total 141 
Continued 
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Table 12. Continued 
 
Bivariate fit of mandibular second molar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 6.94 5.85 0.0166 
Error 169 1.19 
C. Total 170 
 
Bivariate fit of mandibular third molar by time in treatment. 
 Source df Mean Square F Ratio Prob > F 
Model 1 0.98 0.73 0.3984 
Error 46 1.35 
C. Total 47 
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 12 analysis of variance tables in Table 12, one for each of the regression analysis 
testing the dependency of DA-CA on time in treatment.   
Nine of the 12 tests are statistically significant, confirming a positive 
association between (A) how long the child has been in treatment for ALL (and, 
thereby, the duration of time and the extent of growth that has been impacted by 
treatment) and (B) the magnitude of DA-CA, which is a measure of how 
developmentally delayed the child is relative to his chronological age.  Most of 
these associations are highly significant statistically. 
It is worth evaluating these results in some detail.  Figures 9 through 20 
are scatterplots showing these associations, along with the least-squares 
regression line for each set of data.  There is a significant association for the UC 
between time in treatment and DA-CA (Fig. 9).  The vertical scatter seems to be 
centered on zero at the start of treatment, and the regression line slopes 
downward (i.e., increasing developmental delay) as time progresses (P = 0.007). 
In contrast, neither maxillary premolar’s development is significantly 
associated with time in treatment (Figs. 10, 11), but these may well be artifacts of 
small sample sizes.  Sample sizes for UP1 and UP2 are just 20 and 25, 
respectively.  Neither association is significant statistically (Table 12). 
There is a more reasonable sample size for UM1 (n = 121), and here the 
association is highly significant (Fig. 12).  Inspection shows, however, that the 
association probably is leveraged by cases with long time since treatment.  The  
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Fig. 9. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the maxillary right
canine.  The least-squares regression line also is shown.
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Fig. 10. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the maxillary right first
premolar.  The least-squares regression line also is shown.
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Fig. 11. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the maxillary right
second premolar.  The least-squares regression line also is shown.
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Fig. 12. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the maxillary right first
molar.  The least-squares regression line also is shown.
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Fig. 13. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the maxillary right
second molar.  The least-squares regression line also is shown.
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Fig. 14. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the maxillary right third
molar.  The least-squares regression line also is shown.
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Fig. 15. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the mandibular right
canine.  The least-squares regression line also is shown.
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Fig. 16. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the mandibular right
first premolar.  The least-squares regression line also is shown.
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Fig. 17. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the mandibular right
second premolar.  The least-squares regression line also is shown.
90
-5.0
-4.0
-3.0
-2.0
-1.0
0.0
1.0
2.0
0 2 4 6 8 10 12 14
D
en
ta
l A
ge
-M
in
us
-C
hr
on
ol
og
ic
al
 A
ge
 (Y
ea
rs
)
Time in Treatment (Years)
Fig. 18. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the mandibular right first
molar. The least-squares regression line also is shown.
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Fig. 19. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the mandibular right
second molar.  The least-squares regression line also is shown.
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Fig. 20. Scatterplot between time in treatment on the horizontal
axis and DA-CA on the vertical axis for the mandibular right
third molar.  The least-squares regression line also is shown.
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 association between time and DA-CA is highly significant for UM2 (P = 0.0063), 
as illustrated in Figure 13.  As with these other relationships, DA-CA is centered 
around zero at the start of treatment, and it tends towards more negative values 
(i.e., greater developmental delays) as time progresses. 
The same, highly significant negative relationship was found for UM3 (P = 
0.0004) even though the sample size of scorable UM3 was only 43.  The 
association is shown in Figure. 14. 
The sample sizes of scorable mandibular teeth are much improved 
compared to those in the maxilla.  The association for the canine (Fig. 15) is 
highly significant (P=0.0031).  Also, probably because of the much larger sample 
sizes, the associations for P1 and P2 both are highly significant statistically for 
these mandibular teeth (Figs. 16, 17), with P-values of 0.0006 and <0.0001, 
respectively.   
The same, consistent highly significant negative association between time 
and DA-CA occurred for all these three mandibular molars (Figs. 18, 19, 20).  
Again, the greater consistency in these relationships compared to findings for the 
maxillary teeth seems to be attributable to the much larger scorable sample sizes 
for the mandibular teeth.   
In summary, there is strong evidence (Table 12) that (A) the stress of 
treatment for ALL has a decided negative effect on developmental age as 
measured with the dentition (so-called “dental age”) and (B) the longer the time 
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 since treatment initiation, the greater the DA-CA discrepancy.  It also is readily 
evident that there is to be no compensatory growth after the termination of 
treatment.  At this exploratory level—without analysis of individual’s patterns of 
dental development—there is no graphical suggestion that DA-CA in any way 
rebounds several years after diagnosis and treatment of ALL.  As cautionary 
notes, these analyses have combined boys and girls (i.e., not yet tested for sexual 
dimorphism) and have not distinguished between children treated just with 
chemotherapy versus those who also received radiation therapy (Birkebaek and 
Clausen 1998; Halton et al. 1998; Jaruratanasirikul et al. 2004; Shusterman and 
Meadows 2000; Yamashita et al. 2003). 
 
Tooth Development During Treatment 
It was shown early in this chapter that DA-CA became a larger negative 
value as time from treatment progressed.  The purpose in this section is to 
evaluate this trend more closely. 
It needs to be appreciated that, strictly, the dental age data collected here 
constitutes a mixed longitudinal sample.  There are multiple panoramic 
radiographs for most of the children in the study, though they were not taken at 
any set interval.  Instead, they are the examinations that were obtained by the 
staff pediatric dentist to assess, restore, and maintain the oral health of these 
critically sick children.  It was not intended at the time that these radiographs 
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 would be used to monitor the children’s tempo of dental development.  In 
consequence (Fig. 21), most examinations were obtained soon after the child 
arrived at St. Jude’s, which coincides closely with the age at diagnosis and with 
the age at the start of treatment.  The distribution of radiographs is strongly 
positively skewed; comparatively few images were taken years after diagnosis or 
after the cessation of treatment.  For the present study, this means that, while 
there are multiple radiographs (and, thus, multiple assessments of dental age) for 
most of the 72 children, most of the data are clustered close to the start of 
treatment. 
We investigated several ways of partitioning the data in order to produce 
longitudinal series of data representing the different phases of treatment, but 
with no success.  Because of the strongly skewed distribution, it was not possible 
to generate sequences of observation where sample sizes were reliable.  Even 
simply dichotomizing the radiographs into those that were less than 3 years into 
treatment versus those taken later after treatment provided sample sizes only on 
the order of 12 to 15, which were too small to yield informative statistical results.  
In short, most data were clustered within too short a span near the start of 
treatment to provide informative longitudinal assessments of the effect of 
treatment on tooth development. 
Instead, there is more statistical power in treating these data cross-
sectionally than if repeated-measures designs were used with critically small  
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Fig. 21. Bar chart of the distribution of panoramic radiographs
in the present study as a function of time into treatment.  Most
films were taken within 2 years of the initiation of treatment.
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 sample sizes.  Given the skewed distribution of the panoramic radiographs (most 
radiographs were taken within 2 years of the start of treatment) and the 
statistical need to obtain adequate sample sizes per group, four time intervals 
were developed, namely (1) radiographs within 1 year of the start of treatment, 
(2) radiographs between 1 and 2 years of the start, (3) radiographs between 2 and 
3 years, and (4) radiographs taken more than 3 years after the start of treatment. 
Then, for each mandibular tooth type (sample sizes were too small for the 
maxillary teeth), the DA-CA value from each radiograph was grouped into one 
of the four time intervals.  Expectation was that DA-CA would be centered on 
zero at the start of treatment and that mean DA-CA would become a 
progressively larger negative number across the subsequent three time intervals 
as tooth development was retarded by treatment.  The observed results were in 
concert with that expectation. 
Results for each of the six mandibular tooth types (mandibular incisors 
were omitted) are graphed in Figures 22 though 27, and the corresponding 
statistical tests (from one-way analysis of variance) are listed in Table 13.  
Descriptive statistics for DA-CA partitioned by age interval are listed in Table 14.  
Notice that the sample sizes are proportional across the four time intervals.  
Sample sizes are small for the third molars. 
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Fig. 22. Plot of the mean values of DA-CA for the mandibular canine
where time in treatment is partitioned into four intervals.  Error bars
are the standard error of the mean.
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Fig. 23. Plot of the mean values of DA-CA for the mandibular first
premolar where time in treatment is partitioned into four intervals.
Error bars are the standard error of the mean.
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Fig. 24. Plot of the mean values of DA-CA for the mandibular second
premolar where time in treatment is partitioned into four intervals.
Error bars are the standard error of the mean.
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Fig. 25. Plot of the mean values of DA-CA for the mandibular first
molar where time in treatment is partitioned into four intervals.
Error bars are the standard error of the mean.
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Fig. 26. Plot of the mean values of DA-CA for the mandibular
second molar where time in treatment is partitioned into four
intervals.  Error bars are the standard error of the mean.
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Fig. 27. Plot of the mean values of DA-CA for the mandibular third
molar where time in treatment is partitioned into four intervals.
Error bars are the standard error of the mean.
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Table 13.  Results of one-way analysis of variance testing for differences in 
DA-CA among four intervals of time in treatment (and treating the data cross-
sectionally). 
 
   Sum of Mean 
 Source df Squares Square F Ratio Prob > F 
Md Canine 
Time in TX 3 20.19 6.73 5.08 0.0022 
Error 152 201.41 1.33 
Md First Premolar  
Time in TX 3 18.87 6.29 5.04 0.0023 
Error 163 203.30 1.25 
Md Second Premolar 
Time in TX 3 15.16 5.05 4.24 0.0065 
Error 156 185.77 1.19 
Md First Molar 
Time in TX 3 18.50 6.16 5.26 0.0018 
Error 138 161.90 1.17 
Md Second Molar 
Time in TX 3 12.94 4.31 3.70 0.0129 
Error 167 194.46 1.16 
Md Third Molar 
Time in TX 3 1.96 0.65 0.47 0.7047 
Error 44 61.14 1.39 
All Scorable Teeth 
Time in TX 3 12.94 4.31 4.49 0.0046 
Error 184 176.77 0.96 
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 Treatment for ALL had no apparent effect on the rate of formation of the 
mandibular canine until 3 years after the start of treatment (Fig. 22), when DA-
CA dropped significantly (P = 0.0025).  The same pattern was found for the first 
and second premolars (Figs. 23, 24), but the drop in DA-CA was seen after 2 
years of treatment instead of 3. 
The pattern of response for M1 and M2 (Figs. 25 and 26) each shows a 
decrease in DA-CA after the second year, but, statistically, the single source of 
the significance is the obvious decrease after year 3 of treatment. 
The mandibular third molar (Fig. 27) stands out as the one case of the six 
tested where there was no statistically significant difference across time (P = 
0.73), but, as noted (Table 14), this lack of a statistical difference may be 
attributable to the small sample sizes. 
To pursue this approach one step farther, Figure 28 is a graph of DA-CA 
across the four time intervals calculated from all scorable teeth (maxillary and 
mandibular).  These data show that tooth development proceeded on a normal 
course during the first two years of treatment, but a developmental delay is 
evident during the third year, with a highly significant delay after the third year 
(Table 13; P = 0.0046). 
Noteworthy results that are consistent across these several analyses (Table 
13) are (1) that tooth development appears to be undisturbed until the third year 
after the start of treatment—but this does not necessarily address  
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Fig. 28. Plot of the mean values of DA-CA for the average of all
scorable teeth where time in treatment is partitioned into four
intervals.  Error bars are the standard error of the mean.
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 when the damage was incurred—(2) the long-term effect (> 3 years) seems to be 
more dramatic, and (3) there is no suggestion of any sort of compensatory spurt 
in development after treatment.  An additional point is that the considerable 
variability seen in the “over 3” category indicates that some children fare much 
better than others long-term and, as well, other children experience serious 
delays in dental development. 
 
Cranial Irradiation 
 One-third of the 72 children studied (25/72) had been treated with cranial 
irradiation in addition to chemotherapy.  The use of irradiation was just as 
common in boys (26/41; 63%) as girls (21/31; 68%), yielding a chi-square statistic 
of 0.150 (P = 0.7021). 
 So too, the age at diagnosis was statistically independent whether the 
child was treated with irradiation.  Mean age of children treated with irradiation 
(x¯  = 6.8) was the same as those treated with chemotherapy alone (x¯  = 6.7).  By 
ANOVA, this difference between means was insignificant (F = 0.4 with 1 and 71 
df; P = 0.8498). 
 Does cranial irradiation alter the rate of tooth development versus treating 
children diagnosed with ALL with chemotherapy alone?  We looked at DA – CA 
against cranial irradiation (scored as yes or no), with time-in-treatment as a 
covariate.  Results (Table 15) show, importantly, that there is significant  
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Table 15. ANOVA results assessing the effect of time-in-
treatment on DA-CA partitioned by whether the child was 
treated with cranial irradiation.1
 
 Source df Sum of Squares F-Ratio P-Value 
Irradiation 1 0.555744 0.7264 0.3952 
Time in TX 1 5.391796 7.0471 0.0086 
Interaction 1 8.870618 11.5940 0.0008 
1Notice that the irradiation-by-time in treatment interaction 
effect is significant statistically. 
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 interaction between time-in-treatment and whether the patient received cranial 
irradiation (P = 0.03).  This means that the effect of duration on CA –DA is 
different depending on whether treatment involved irradiation. 
 Without irradiation (Table 16), the dependency disappears (n = 112 
examinations; F = 0.26; P = 0.6138).  With irradiation, there is a highly significant 
association between time-in-treatment and the delay in DA behind CA (F = 20.31; 
P < 0.0001) based on 78 examinations (Table 17).  We also tested for an effect due 
to sex of the patient, but there was no difference in the response of boys and 
girls.  Examining the data (DA – CA) for children who received cranial 
irradiation, the association was linear insofar as a quadratic equation did not 
significantly improve the fit.  Tests were performed for the six mandibular teeth 
(canine through third molar) and for the summary measure of all scorable teeth.  
Data are too sparse to analyze the maxillary teeth individually.  The fit of linear 
regression lines to the data are shown in Figures 29 through 35.  In each instance, 
the regression coefficient has a significant negative slope for the subset of 
children treated with cranial irradiation, but the regression coefficient is always 
zero for the group receiving chemotherapy alone. 
 These results are important because they disclose (A) that the debilitating 
effect of treatment on dental development is predominately driven by the cranial 
irradiation and (B) chemotherapy alone has a nonsignificant effect on dental 
maturation. 
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Table 16. ANOVA results assessing the effect of time-in-
treatment on DA-CA in the subset of the sample that was 
treated with chemotherapy alone. 
 
 Source df Sum of Squares F-Ratio P-Value 
Time in TX 1 .01929952 0.2561 0.6138 
 
 
 
Table 17. ANOVA results assessing the effect of time-in-
treatment on DA-CA in the subset of the sample that was 
treated with chemotherapy and cranial irradiation. 
 
 Source df Sum of Squares F-Ratio P-Value 
Time in TX 1 15.890743 20.3058 < 0.0001 
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Fig. 29. Plot of time in treatment against DA-CA, with the data
(mandibular canine) partitioned by whether the child was treated
with cranial irradiation or chemotherapy alone.
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Fig. 31. Plot of time in treatment against DA-CA, with the data
(mandibular second premolar) partitioned by whether the child was
treated with cranial irradiation or chemotherapy alone.
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Fig. 32. Plot of time in treatment against DA-CA, with the data
(mandibular first molar) partitioned by whether the child was treated
with cranial irradiation or chemotherapy alone.
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Fig. 33. Plot of time in treatment against DA-CA, with the data
(mandibular second molar) partitioned by whether the child was
treated with cranial irradiation or chemotherapy alone.
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Fig. 34. Plot of time in treatment against DA-CA, with the data
(mandibular third molar) partitioned by whether the child was
treated with cranial irradiation or chemotherapy alone.
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Fig. 35. Plot of time in treatment against DA-CA, with the data
(average of all scorable teeth) partitioned by whether the child was
treated with cranial irradiation or chemotherapy alone.
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 CHAPTER V 
 
DISCUSSION 
 
Perspective 
 Leukemia is the most frequent form of childhood cancer, comprising 
about one-third of all cancers in children.  Acute lymphoblastic leukemia (ALL) 
involves approximately 80 percent of all childhood leukemias (Zipf et al. 2000) 
and was the leading cause of death among children in the United States until the 
early 1980s (Pui and Evans 1998).  
 ALL is diagnosed in 2,500 to 3,500 children each year in the United States.  
This category of disease strikes children primarily between 2 and 10 years of age, 
with the peak incidence between age 2 and 5 years (Swensen et al. 1997).  ALL is 
more common in white than black children in the United States.  It also is more 
common in boys than girls, and this sex difference is greatest during puberty 
(Swensen et al. 1997; Haddy 1982). 
 Although the cause of ALL remains unknown, there are a number of 
genetic, environmental, viral, and immunological factors that may contribute to 
development of the disease.  An heightened susceptibility to leukemia has been 
associated with certain heritable diseases, chromosomal disorders, and 
constitutional syndromes (Mahoney 1999).  Exposure to ionizing radiation is an 
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 environmental factor shown to have carcinogenic effects (Lyon et al. 1979).  
Several viruses have exhibited associations with leukemia.  These include the 
human T-cell lymphotrophic virus (HTLV-I), which is a retrovirus isolated from 
a subset of patients with adult T-cell leukemia, the Epstein-Barr virus with 
African Burkitt’s lymphoma, and the HTLV-II virus with atypical hairy-cell 
leukemia (Perkins et al. 1997; Mahoney 1999).  Several immunodeficiency states 
also carry increased risks for leukemia.  These conditions include the syndromes 
of Wiskott-Aldrich, congenital hypogammaglobulinemia, X-linked 
agammaglobulinemia, and severe combined immune deficiency (Mahoney 1999; 
Margolin et al. 2002).  
 Patients with ALL present most frequently with signs of the uncontrolled 
growth of leukemic cells in bone marrow, lymphoid structures, and other sites of 
extramedullary spread (e.g., CNS, testes, lymph nodes, liver, spleen, and kidney) 
(Berg et al. 2000).  The most common presenting symptoms are fever, pallor, 
purpura, and pain (Mahoney 1999).  Bone marrow involvement results in 
varying degrees of anemia, thrombocytopenia, and granulocytopenia that may 
be manifested by pallor and fatigue, petechiae, purpura or bleeding, and fever 
(Berg et al. 2000).  Bleeding problems range from mild complications such as 
petechiae, bruising, and mucosal bleeding, to severe problems such as 
gastrointestinal bleeding and CNS hemorrhage (Perkins et al. 1997).  Oral 
manifestations of ALL include petechiae and ecchymosis, pallor, ulcers, and 
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 bleeding (Curtis 1971a).  Overall signs and symptoms depend on a range of 
factors including age of onset, duration of treatment, and subtype of ALL.  Since 
ALL is such a rapidly progressing disease, the radiographic signs are not 
detectable until later, usually further into the progression of the disease or well 
into treatment. 
 The overall prognosis of patients with ALL is promising as rates of 
remission continue to increase.  Remission rates for children are currently near 80 
percent, which reflects the obvious progress that has been made in the treatment 
of ALL (Pui 1997). 
 Treatments for ALL have negative effects on the normal cells of the body, 
so children’s tempos of growth may be affected iatrogenically by treatment.  We 
hypothesized in the present study that children’s tempo of dental maturation 
would slow during treatment.  The purpose of this study was to quantitatively 
assess the effects of treatment for ALL on the tempo of dental maturation 
evaluated as dental age (see concepts in Demirjian 1978), including the degree to 
which the tempo of tooth mineralization is altered during treatment. 
 
Dental Age 
 The present retrospective study examined the panoramic radiographs of 
72 children (31 girls and 41 boys) who had been treated for ALL at St. Jude 
Children’s Research Hospital, Memphis, Tennessee.  Mean chronological age at 
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 diagnosis was 6.8 years (sd = 2.11), with a range of 3.1 to 10.5 years of age.  
Panoramic radiographs were taken of these children by the staff pediatric dentist 
as indicated for routine restorative dental work.  As such, radiographs were not 
taken at any set interval, and the timing and number of films varied appreciably 
among the children. 
Few studies have assessed dental maturation in children treated for ALL.  
There are, however, many reports in the literature on the various morphological 
dental abnormalities associated with treatment of the disease (Kaste et al. 1997; 
Minicucci et al. 2003; Rosenberg et al. 1987), increased caries with chemotherapy 
(Bertolone et al. 1981; Purdell-Lewis et al. 1988; Pajari et al. 1988), delayed 
emergence in children treated with chemotherapy (Adatia 1968; Cetiner and 
Alpaslan 2004), and how these dental abnormalities can affect an orthodontist’s 
treatment Dahllöf et al. (2001).  All of these studies describe morphological dental 
sequelae that occur from the treatment of ALL.  It does not appear that any of the 
aforementioned studies investigated whether treatment discernibly affects these 
children’s tempo of dental development.  The present study quantified the dental 
status (i.e., stage of crown-root formation) of all developing permanent teeth and 
compared them to sex-specific American white standards published by Harris 
and McKee (1990). 
Statistical analysis showed (1) that DA is unaffected at the onset of 
treatment and that (2) DA-CA (the extent of delay) increases as treatment 
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 progressed.  One anticipates that, as a child ages, his maturational indicators 
(e.g., dental age and bone age) should increase apace.  A severe stress—like 
treatment for ALL—should, in turn, slow-down the child’s growth tempos (e.g., 
Kirk et al. 1987; Dahllöf et al. 1989a; Birkebaek and Clausen 1998;).  In turn, 
expectation is that, with resolution of the stressor, the tempos of growth ought to 
resume to a normal pace. 
A study by Tamminga et al. (1993) showed that during treatment for ALL 
the tempo of bone maturation as well as height growth was retarded in relation 
to calendar age.  A catch-up of bone age and of height was observed in the 2 
years after cessation of treatment.  Other investigators have used height and 
weight to assess the development of children treated for ALL.  Dalton et al. (2003) 
found a slight decrease in height in children treated for ALL and received cranial 
irradiation in addition to chemotherapy.  This decrease, however, was not 
statistically significant when these children were compared to non-irradiated 
children. 
Kirk et al. (1987) reported several cases of diminished stature in children 
treated with chemotherapy and with irradiation for ALL.  Stature had decreased 
by more than one standard deviation in 32 percent of survivors at 4 years post-
diagnosis and in 71 percent at 6 years post-diagnosis.  They also found that 
growth of younger children and those children especially tall for their age at 
diagnosis experienced greater depression in the rate of growth of stature. 
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 Holm et al. (1994) and Birkebaek and Clausen (1998) showed that the 
height standard deviation scores were decreased during treatment only to have 
catch-up growth and the height standard deviation scores return to normal at the 
final observation period.  Holm et al. (1994) examined 28 patients that were 
treated for ALL with chemotherapy only and Birkebaek and Clausen (1998) 
sample included 11 patients with chemotherapy only and 22 that had added 
irradiation therapy. 
 
Response Between Sexes 
There was no sex difference found in the dependency between age and 
DA-CA.  It is known from the literature that boys have a worse prognosis than 
girls with ALL in terms of survival (Ishii et al. 2001; Shanta et al. 1996; Pui et al. 
1999), but this sex difference does not appear to carry over to developmental 
delay within survivors. 
 
Chemotherapy Treatment Alone 
A study by Macleod et al. (1987) examined the cytotoxic effects of 
chemotherapy on the formation of dental tissues.  Extracted teeth were collected 
from patients receiving various cytotoxic chemotherapeutic regimens for 
malignant disease.  Children who had received radiotherapy to the jaws were 
excluded from the study.  Slides were prepared to examine incremental lines, 
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 which correlated with intravenous drug administration, in both the dentine and 
enamel.  The only formative disturbances that were found involved 
dentinogenesis.  In teeth where amelogenesis would have been occurring at the 
time of treatment, the enamel appeared normal.  Furthermore, the dentin that 
was formed during chemotherapy was hypermineralized compared to dentine 
formed before and after treatment and no related areas of hypomineralization 
were seen. 
In the present study the data were partitioned into (1) children treated 
with only chemotherapy and (2) those treated with chemotherapy and 
irradiation.  Examining the data for children treated with chemotherapy, there 
was no effect on the tempo of dental maturation.  Our findings are based on a 
larger sample and in agreement with Dahllöf et al. (1989b) who reported no 
statistical difference of dental maturation in patients treated with just 
chemotherapy for ALL and AML.  Their sample consisted of 44 Swedish patients 
who presented for bone marrow transplant.  Each patient was matched with 
healthy controls for age and sex.  Included in the 44 patients, were 28 with the 
diagnosis of ALL.  The method described by Demirjian and Goldstein (1976) was 
used to score dental maturation in their study.  Dahllöf et al. (1989b) compared 
their results to two studies, namely (1) by Purdell-Lewis et al. (1988) who 
reported a delay in tooth formation in 8 of 45 long term survivors of childhood 
cancer treated with chemotherapy and (2) by Adatia (1968) who reported 
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 delayed emergence eruption in one of 13 patients treated with 
cyclophosphamide, methotrexate, and vincristine for Burkitt’s tumor. 
Purdell-Lewis et al. (1988) studied 45 children treated with chemotherapy 
for various cancers (i.e., ALL, neuroblastoma, Wilm’s tumor, 
rhabdomyosarcoma, histiocytosis X, and acute non-lymphatic leukemia).  It is 
important to note that the 23 ALL patients in the sample of 45 also had 
prophylactic CNS radiation therapy; the ALL patients studied by Purdell-Lewis 
et al. (1988) did not receive only chemotherapy.  The results of Dahllöf et al. 
(1989b) should only be comparable to studies that include patients treated for 
ALL with chemotherapy only.  Also, the Adatia (1968) study did not include any 
ALL patients and had one patient who exhibited delayed emergence (which is a 
weak indicator of dental maturity).  This explains how the sample in the present 
study serves as the best comparable sample to the study by Dahllöf et al. (1989b). 
 
Cranial Irradiation
 When the data were separated for patients receiving cranial irradiation in 
addition to chemotherapy, a significant difference was seen.  It is know that 
irradiation therapy targets actively dividing cells and those normal cells within 
the field of irradiation will be adversely affected.  In order for a tooth root to 
develop the odontoblast must replicate along the long axis of the forming tooth 
root away from the newly formed crown.  When the odontoblasts are irradiated, 
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 the mitotic activity is altered and the replication slows or ceases.  Once the 
odontoblasts are altered or destroyed, the tooth root has lost the ability to form to 
its genetic potential.   
The tooth crown differs in that the ameloblasts must replicate to form the 
outline of the crown, but once the initial outline is formed, mitosis no longer 
occurs.  The ameloblasts merely secretes the matrix that calcifies to form enamel.  
Since the irradiation can affect the initial crown outline form, disturbances of 
crown formation is seen in the teeth in which crown formation was initiated 
during treatment with cranial irradiation. 
If we examine dental development in normal children, the teeth will 
eventually reach maturity and, in an unaffected mature tooth, the morphology 
should resemble the final grade of apex closure shown in Figure 4.  In children 
who received irradiation therapy the developing tooth root is malformed (e.g., 
stunted or blunted, tapered, open apices, microdont) or missing.  These teeth 
have not had the opportunity to complete normal maturation.  We speculate that 
this explains why we see that the longer a child is in treatment for ALL, with 
cranial irradiation, the more dentally delayed the child appears.  The dental ages 
of the affected teeth are calculated using morphological grading schemes of 
normally developing teeth.  This proposes a problem in that the affected teeth 
have, in a sense, matured to their fullest extent possible but they appear under 
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 developed according to the grades and descriptions in Figure 4 and Table 7, 
respectively. 
Näsman et al. (1997) examined the dental radiographs of 16 children 
conditioned with total body irradiation and cyclophosphamide prior to bone 
marrow transplantation, and 52 children treated with multiagent chemotherapy.  
In the 16 children who had irradiation it was unclear as to how many had ALL.  
Also, of the 52 children treated with chemotherapy, only 19 had ALL.  
Additionally, 13 of the 52 children had irradiation along with chemotherapy.  
This resulted in a reduced sample size to 19 patients diagnosed with ALL and 
possibly including patients that received additional irradiation along with 
chemotherapy.   Näsman et al. (1997) concluded that (1) when treatment was 
initiated in children below 12 years of age, all teeth are negatively affected by 
antineoplastic therapy, (2) children treated with irradiation exhibited 
significantly more disturbances in dental development than children treated with 
multiagent chemotherapy, and (3) there was a reduction in tooth size as a result 
of chemotherapy or radiation therapy, but the children receiving irradiation 
exhibited the most extensive reduction.  Dahllöf et al. (1989b) and Näsman et al. 
(1997) seem to be the closest comparable studies to that conducted in this thesis. 
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 Onset of Dental Age Delay
Our results showed that dental maturation is only slightly affected by 
chemotherapy alone, whereas chemotherapy combined with irradiation has a 
decidedly negative effect on dental maturation.  Results in the present study 
show that the delay does not become evident until two years after treatment.  We 
hypothesize this delay is because of (1) the grading scale that was used has 
approximately six months between grades, (2) the delayed effects on 
mineralization takes time to become evident radiographically, and (3) the 
variability in the cross-sectional design of the analysis does not allow 
examination of intra-individual trends. 
 
Orthodontic Treatment of Survivors 
Dahllöf et al. (2001) conducted a survey of orthodontists who had 
performed treatment of post-cancer children.  The orthodontists reported that (1) 
the patient’s medical condition influenced their choice of treatment plan, (2) they 
used lighter forces in patients with severely disturbed root development, (3) one 
orthodontist reported root resorption, and (4) in 4 of 10 patients, the treatment 
result was judged to be unsatisfactory.  They concluded that although ideal 
treatment results were not always achieved, orthodontic treatment did not 
produce harmful side effects in children who are long-term survivors of 
childhood cancer. 
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 CHAPTER VI 
 
SUMMARY AND CONCLUSIONS 
 
Leukemia is the most frequent form of childhood cancer, comprising 
about one-third of all cancers in children.  This category of disease strikes 
children primarily between 2 and 10 years of age, with the peak incidence of ALL 
occurring between age 2 and 5 years.  Treatment strategies for ALL consist of 
chemotherapy with or without irradiation of the neck and/or spine. 
The present study used panoramic radiographs to determine the dental 
maturation of children treated for ALL.  Dental age based on the degrees of 
crown-root development was assessed on  a total of 190 panoramic radiographs 
from 72 children (41 boys, 31 girls) treated at St. Jude Children’s Research 
Hospital, Memphis, Tennessee.  Mean chronological age at diagnosis was 6.8 
years (sd = 2.11), with a range of 3.1 to 10.5 years.  Dental ages for each 
radiograph were scored using the grading schemes of Moorrees, Fanning and 
Hunt (1963) and the published norms of Harris and McKee (1990). 
The children’s dental ages were normal at diagnosis for ALL and before 
commencement of treatment.  We supposed that treatments for ALL would 
discernibly depress the children’s tempos of growth, an analysis confirmed this 
hypothesis. 
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 In the children receiving only chemotherapy, treatment did not affect 
dental development to any statically significant extent.  Due to the severe stress 
irradiation has on the dentition, children receiving both chemotherapy and 
irradiation experienced a decided delay in dental development, but the effects 
were not seen radiographically until 2 years after the start; the longer the 
children were into treatment the more the dental age was delayed. 
Although orthodontic treatment might not produce any harmful side 
effects, the orthodontist must be aware of the dental conditions and disturbances 
which exist in patients treated for ALL.  The orthodontist should also consider 
the dental sequelae of cranial irradiation, such as missing or malformed teeth, 
delayed development and eruption, and shortened or tapered roots that can alter 
the normal course of orthodontic treatment. 
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Appendix A 
Plots of dental age (averaged over all scorable teeth) against chronological age. 
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Fig. A-1. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#1).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-2. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#2).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-3. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#3).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-4. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#4).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-5. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#5).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-6. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#6).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-7. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#7).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-8. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#8).  The square symbol denotes age at diagnosis of ALL.  One
examination that was beyond the age of 14 was omitted for
consistency.
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Fig. A-9. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#9).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-10. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#10).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-11. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#11).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-12. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#12).  The square symbol denotes age at diagnosis of ALL.
167
BJ
H F
3
PM
Å
0
2
4
6
8
10
12
14
0 2 4 6 8 10 12 14
A
ve
ra
ge
 D
en
ta
l A
ge
Chronological Age
Fig. A-13. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#13).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-14. Plot of chronological age against dental age averaged across
all scorable teeth (symbols) for a male (pseudo-record #14).  The
square symbol denotes age at diagnosis of ALL.
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Fig. A-15. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#15).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-16. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#16).  The square symbol denotes age at diagnosis of ALL.  One
examination that was beyond the age of 14 was omitted for
consistency.
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Fig. A-17. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#17).  The square symbol denotes age at diagnosis of ALL.  One
examination that was beyond the age of 14 was omitted for
consistency.
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Fig. A-18. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#18).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-19. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#19).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-20. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#20).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-21. Plot of chronological age against dental age averaged
across all scorable teeth (symbol) for a male (pseudo-record
#21).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-22. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#22).  The square symbol denotes age at diagnosis of ALL.
177
B
J
H
F
0
2
4
6
8
10
12
14
0 2 4 6 8 10 12 14
A
ve
ra
ge
 D
en
ta
l A
ge
Chronological Age
Fig. A-23. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#23).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-24. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#24).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-25. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#25).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-26. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#26).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-27. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#27).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-28. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#28).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-29. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#29).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-30. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#30).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-31. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#31).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-32. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#32).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-33. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#33).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-34. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#34).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-35. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#35).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-36. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#36).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-37. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#37).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-38. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#38).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-39. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#39).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-40. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#40).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-41. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#41).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-42. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#42).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-43. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#43).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-44. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#44).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-45. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#45).  The square symbol denotes age at diagnosis of ALL.
200
B
J
H
0
2
4
6
8
10
12
14
0 2 4 6 8 10 12 14
A
ve
ra
ge
 D
en
ta
l A
ge
Chronological Age
Fig. A-46. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#46).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-47. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#47).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-48. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#48).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-49. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#49).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-50. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#50).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-51. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#51).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-52. Plot of chronological age against dental age averaged
across all scorable teeth (symbol) for a male (pseudo-record
#52).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-53. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#53).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-54. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#54).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-55. Plot of chronological age against dental age averaged
across all scorable teeth (symbol) for a female (pseudo-record
#55).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-56. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#56).  The square symbol denotes age at diagnosis of ALL.
211
Fig. A-57. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#57).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-58. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#58).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-59. Plot of chronological age against dental age averaged
across all scorable teeth (symbol) for a female (pseudo-record
#59).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-60. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#60).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-61. Plot of chronological age against dental age averaged
across all scorable teeth (symbol) for a male (pseudo-record
#61).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-62. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#62).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-63. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#63).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-64. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#64).  The square symbol denotes age at diagnosis of ALL.
219
BJ
H
0
2
4
6
8
10
12
14
0 2 4 6 8 10 12 14
A
ve
ra
ge
 D
en
ta
l A
ge
Chronological Age
Fig. A-65. Plot of chronological age against dental age averaged across
all scorable teeth (symbols) for a female (pseudo-record #65).  The
square symbol denotes age at diagnosis of ALL.
220
BJ
H
0
2
4
6
8
10
12
14
0 2 4 6 8 10 12 14
A
ve
ra
ge
 D
en
ta
l A
ge
Chronological Age
Fig. A-66. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#66).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-67. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#67).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-68. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a male (pseudo-record
#68).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-69. Plot of chronological age against dental age averaged
across all scorable teeth (symbol) for a female (pseudo-record
#69).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-70. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#70).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-71. Plot of chronological age against dental age averaged
across all scorable teeth (symbols) for a female (pseudo-record
#71).  The square symbol denotes age at diagnosis of ALL.
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Fig. A-72. Plot of chronological age against dental age averaged across
all scorable teeth (symbols) for a female (pseudo-record #72).  The
square symbol denotes age at diagnosis of ALL.
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Appendix B 
Plots of tooth-specific results of DA-CA for each child in this study.  All 
examinations (i.e., all panoral radiographs) available for a patient are plotted in 
the graph.  Note that the vertical scale (DA minus CA) normally is set to the 
range of +3 to -3 years, but this is exceeded for some cases with extreme values. 
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